id sid tid token lemma pos ct-9360 1 1 luteinizing luteinize VERB ct-9360 1 2 hormone hormone NOUN ct-9360 1 3 receptor receptor NOUN ct-9360 1 4 expression expression NOUN ct-9360 1 5 in in ADP ct-9360 1 6 lymphoma lymphoma NOUN ct-9360 1 7 is be AUX ct-9360 1 8 not not PART ct-9360 1 9 affected affect VERB ct-9360 1 10 by by ADP ct-9360 1 11 body body NOUN ct-9360 1 12 weight weight NOUN ct-9360 1 13 , , PUNCT ct-9360 1 14 sex sex NOUN ct-9360 1 15 , , PUNCT ct-9360 1 16 immunophenotype immunophenotype NOUN ct-9360 1 17 , , PUNCT ct-9360 1 18 or or CCONJ ct-9360 1 19 tumor tumor NOUN ct-9360 1 20 stage stage NOUN ct-9360 1 21 in in ADP ct-9360 1 22 gonadectomized gonadectomize VERB ct-9360 1 23 dogs dog NOUN ct-9360 1 24 khawla khawla PROPN ct-9360 1 25 zwida zwida PROPN ct-9360 1 26 , , PUNCT ct-9360 1 27 alyssa alyssa PROPN ct-9360 1 28 vedus vedus NOUN ct-9360 1 29 , , PUNCT ct-9360 1 30 michelle michelle PROPN ct-9360 1 31 kutzler kutzler PROPN ct-9360 1 32 department department PROPN ct-9360 1 33 of of ADP ct-9360 1 34 animal animal NOUN ct-9360 1 35 and and CCONJ ct-9360 1 36 rangeland rangeland NOUN ct-9360 1 37 sciences science NOUN ct-9360 1 38 , , PUNCT ct-9360 1 39 oregon oregon PROPN ct-9360 1 40 state state PROPN ct-9360 1 41 university university PROPN ct-9360 1 42 , , PUNCT ct-9360 1 43 corvallis corvallis PROPN ct-9360 1 44 , , PUNCT ct-9360 1 45 or or CCONJ ct-9360 1 46 abstract abstract ADJ ct-9360 1 47 purpose purpose NOUN ct-9360 1 48 of of ADP ct-9360 1 49 this this DET ct-9360 1 50 investigation investigation NOUN ct-9360 1 51 was be AUX ct-9360 1 52 to to PART ct-9360 1 53 determine determine VERB ct-9360 1 54 if if SCONJ ct-9360 1 55 luteinizing luteinize VERB ct-9360 1 56 hormone hormone NOUN ct-9360 1 57 receptor receptor NOUN ct-9360 1 58 ( ( PUNCT ct-9360 1 59 lhr lhr ADJ ct-9360 1 60 ) ) PUNCT ct-9360 1 61 expression expression NOUN ct-9360 1 62 in in ADP ct-9360 1 63 canine canine NOUN ct-9360 1 64 lymphoma lymphoma NOUN ct-9360 1 65 was be AUX ct-9360 1 66 affected affect VERB ct-9360 1 67 by by ADP ct-9360 1 68 body body NOUN ct-9360 1 69 weight weight NOUN ct-9360 1 70 , , PUNCT ct-9360 1 71 sex sex NOUN ct-9360 1 72 , , PUNCT ct-9360 1 73 immunophenotype immunophenotype NOUN ct-9360 1 74 ( ( PUNCT ct-9360 1 75 b b NOUN ct-9360 1 76 cell cell NOUN ct-9360 1 77 , , PUNCT ct-9360 1 78 t t NOUN ct-9360 1 79 cell cell NOUN ct-9360 1 80 ) ) PUNCT ct-9360 1 81 or or CCONJ ct-9360 1 82 tumor tumor NOUN ct-9360 1 83 stage stage NOUN ct-9360 1 84 . . PUNCT ct-9360 2 1 formalin formalin NOUN ct-9360 2 2 - - PUNCT ct-9360 2 3 fixed fix VERB ct-9360 2 4 , , PUNCT ct-9360 2 5 paraffin paraffin NOUN ct-9360 2 6 - - PUNCT ct-9360 2 7 embedded embed VERB ct-9360 2 8 lymphoma lymphoma NOUN ct-9360 2 9 tissue tissue NOUN ct-9360 2 10 samples sample NOUN ct-9360 2 11 from from ADP ct-9360 2 12 spayed spay VERB ct-9360 2 13 and and CCONJ ct-9360 2 14 neutered neutered ADJ ct-9360 2 15 dogs dog NOUN ct-9360 2 16 ( ( PUNCT ct-9360 2 17 n n NOUN ct-9360 2 18 = = NUM ct-9360 2 19 40 40 NUM ct-9360 2 20 ) ) PUNCT ct-9360 2 21 , , PUNCT ct-9360 2 22 representing represent VERB ct-9360 2 23 multiple multiple ADJ ct-9360 2 24 breeds breed NOUN ct-9360 2 25 and and CCONJ ct-9360 2 26 mixed mixed ADJ ct-9360 2 27 breeds breed NOUN ct-9360 2 28 , , PUNCT ct-9360 2 29 were be AUX ct-9360 2 30 subjected subject VERB ct-9360 2 31 to to ADP ct-9360 2 32 routine routine ADJ ct-9360 2 33 immunohistochemical immunohistochemical ADJ ct-9360 2 34 techniques technique NOUN ct-9360 2 35 using use VERB ct-9360 2 36 a a DET ct-9360 2 37 polyclonal polyclonal ADJ ct-9360 2 38 lhr lhr ADJ ct-9360 2 39 antibody antibody NOUN ct-9360 2 40 . . PUNCT ct-9360 3 1 percentage percentage NOUN ct-9360 3 2 of of ADP ct-9360 3 3 cells cell NOUN ct-9360 3 4 positive positive ADJ ct-9360 3 5 for for ADP ct-9360 3 6 lhr lhr NOUN ct-9360 3 7 and and CCONJ ct-9360 3 8 the the DET ct-9360 3 9 staining stain VERB ct-9360 3 10 intensity intensity NOUN ct-9360 3 11 ( ( PUNCT ct-9360 3 12 scored score VERB ct-9360 3 13 0 0 NUM ct-9360 3 14 3 3 NUM ct-9360 3 15 ) ) PUNCT ct-9360 3 16 were be AUX ct-9360 3 17 determined determine VERB ct-9360 3 18 at at ADP ct-9360 3 19 400 400 NUM ct-9360 3 20 x x NOUN ct-9360 3 21 magnification magnification NOUN ct-9360 3 22 . . PUNCT ct-9360 4 1 data datum NOUN ct-9360 4 2 were be AUX ct-9360 4 3 expressed express VERB ct-9360 4 4 as as ADP ct-9360 4 5 mean mean NOUN ct-9360 4 6 ± ± NUM ct-9360 4 7 standard standard ADJ ct-9360 4 8 deviation deviation NOUN ct-9360 4 9 and and CCONJ ct-9360 4 10 significance significance NOUN ct-9360 4 11 was be AUX ct-9360 4 12 defined define VERB ct-9360 4 13 as as ADP ct-9360 4 14 p p X ct-9360 4 15 < < X ct-9360 4 16 0.05 0.05 NUM ct-9360 4 17 . . PUNCT ct-9360 5 1 differences difference NOUN ct-9360 5 2 between between ADP ct-9360 5 3 sex sex NOUN ct-9360 5 4 and and CCONJ ct-9360 5 5 tumor tumor NOUN ct-9360 5 6 phenotype phenotype NOUN ct-9360 5 7 , , PUNCT ct-9360 5 8 body body NOUN ct-9360 5 9 weight weight NOUN ct-9360 5 10 and and CCONJ ct-9360 5 11 tumor tumor NOUN ct-9360 5 12 stage stage NOUN ct-9360 5 13 were be AUX ct-9360 5 14 compared compare VERB ct-9360 5 15 . . PUNCT ct-9360 6 1 all all DET ct-9360 6 2 tumor tumor NOUN ct-9360 6 3 samples sample NOUN ct-9360 6 4 had have VERB ct-9360 6 5 cells cell NOUN ct-9360 6 6 positive positive ADJ ct-9360 6 7 for for ADP ct-9360 6 8 lhr lhr PROPN ct-9360 6 9 . . PUNCT ct-9360 7 1 however however ADV ct-9360 7 2 , , PUNCT ct-9360 7 3 percentage percentage NOUN ct-9360 7 4 of of ADP ct-9360 7 5 cells cell NOUN ct-9360 7 6 expressing express VERB ct-9360 7 7 lhr lhr PROPN ct-9360 7 8 and and CCONJ ct-9360 7 9 its its PRON ct-9360 7 10 immunostaining immunostaine VERB ct-9360 7 11 intensity intensity NOUN ct-9360 7 12 varied varied ADJ ct-9360 7 13 among among ADP ct-9360 7 14 individuals individual NOUN ct-9360 7 15 . . PUNCT ct-9360 8 1 there there PRON ct-9360 8 2 were be VERB ct-9360 8 3 no no DET ct-9360 8 4 significant significant ADJ ct-9360 8 5 differences difference NOUN ct-9360 8 6 in in ADP ct-9360 8 7 percentage percentage NOUN ct-9360 8 8 of of ADP ct-9360 8 9 lhr lhr ADJ ct-9360 8 10 positive positive ADJ ct-9360 8 11 cells cell NOUN ct-9360 8 12 or or CCONJ ct-9360 8 13 staining stain VERB ct-9360 8 14 intensity intensity NOUN ct-9360 8 15 within within ADP ct-9360 8 16 sex sex NOUN ct-9360 8 17 or or CCONJ ct-9360 8 18 immunophenotype immunophenotype NOUN ct-9360 8 19 . . PUNCT ct-9360 9 1 additionally additionally ADV ct-9360 9 2 , , PUNCT ct-9360 9 3 there there PRON ct-9360 9 4 was be VERB ct-9360 9 5 no no DET ct-9360 9 6 significant significant ADJ ct-9360 9 7 association association NOUN ct-9360 9 8 between between ADP ct-9360 9 9 percentage percentage NOUN ct-9360 9 10 of of ADP ct-9360 9 11 lhr lhr ADJ ct-9360 9 12 positive positive ADJ ct-9360 9 13 cells cell NOUN ct-9360 9 14 or or CCONJ ct-9360 9 15 staining stain VERB ct-9360 9 16 intensity intensity NOUN ct-9360 9 17 within within ADP ct-9360 9 18 body body NOUN ct-9360 9 19 weight weight NOUN ct-9360 9 20 or or CCONJ ct-9360 9 21 tumor tumor NOUN ct-9360 9 22 stage stage NOUN ct-9360 9 23 . . PUNCT ct-9360 10 1 we we PRON ct-9360 10 2 concluded conclude VERB ct-9360 10 3 that that SCONJ ct-9360 10 4 increased increase VERB ct-9360 10 5 risk risk NOUN ct-9360 10 6 of of ADP ct-9360 10 7 lymphoma lymphoma NOUN ct-9360 10 8 in in ADP ct-9360 10 9 spayed spay VERB ct-9360 10 10 and and CCONJ ct-9360 10 11 neutered neuter VERB ct-9360 10 12 dogs dog NOUN ct-9360 10 13 was be AUX ct-9360 10 14 not not PART ct-9360 10 15 related relate VERB ct-9360 10 16 to to ADP ct-9360 10 17 body body NOUN ct-9360 10 18 weight weight NOUN ct-9360 10 19 , , PUNCT ct-9360 10 20 sex sex NOUN ct-9360 10 21 , , PUNCT ct-9360 10 22 immunophenotype immunophenotype NOUN ct-9360 10 23 or or CCONJ ct-9360 10 24 tumor tumor NOUN ct-9360 10 25 stage stage NOUN ct-9360 10 26 . . PUNCT ct-9360 11 1 however however ADV ct-9360 11 2 , , PUNCT ct-9360 11 3 it it PRON ct-9360 11 4 is be AUX ct-9360 11 5 possible possible ADJ ct-9360 11 6 that that SCONJ ct-9360 11 7 risk risk NOUN ct-9360 11 8 of of ADP ct-9360 11 9 lymphoma lymphoma NOUN ct-9360 11 10 may may AUX ct-9360 11 11 be be AUX ct-9360 11 12 related relate VERB ct-9360 11 13 to to ADP ct-9360 11 14 increased increase VERB ct-9360 11 15 lhr lhr ADJ ct-9360 11 16 activation activation NOUN ct-9360 11 17 following follow VERB ct-9360 11 18 gonadectomy gonadectomy NOUN ct-9360 11 19 . . PUNCT ct-9360 12 1 keywords keyword NOUN ct-9360 12 2 : : PUNCT ct-9360 12 3 b b X ct-9360 12 4 cell cell NOUN ct-9360 12 5 , , PUNCT ct-9360 12 6 t t NOUN ct-9360 12 7 cell cell NOUN ct-9360 12 8 , , PUNCT ct-9360 12 9 gonadectomized gonadectomize VERB ct-9360 12 10 dogs dog NOUN ct-9360 12 11 , , PUNCT ct-9360 12 12 lymphoma lymphoma NOUN ct-9360 12 13 , , PUNCT ct-9360 12 14 immunohistochemistry immunohistochemistry NOUN ct-9360 12 15 introduction introduction NOUN ct-9360 12 16 canine canine NOUN ct-9360 12 17 lymphoma lymphoma NOUN ct-9360 12 18 is be AUX ct-9360 12 19 the the DET ct-9360 12 20 most most ADV ct-9360 12 21 common common ADJ ct-9360 12 22 hematopoietic hematopoietic ADJ ct-9360 12 23 neoplasm neoplasm NOUN ct-9360 12 24 in in ADP ct-9360 12 25 the the DET ct-9360 12 26 dog dog NOUN ct-9360 12 27 , , PUNCT ct-9360 12 28 accounting account VERB ct-9360 12 29 for for ADP ct-9360 12 30 up up ADP ct-9360 12 31 to to PART ct-9360 12 32 24 24 NUM ct-9360 12 33 % % NOUN ct-9360 12 34 of of ADP ct-9360 12 35 all all DET ct-9360 12 36 canine canine NOUN ct-9360 12 37 cancers.1,2 cancers.1,2 ADJ ct-9360 12 38 lymphoma lymphoma NOUN ct-9360 12 39 can can AUX ct-9360 12 40 be be AUX ct-9360 12 41 derived derive VERB ct-9360 12 42 from from ADP ct-9360 12 43 either either CCONJ ct-9360 12 44 b b NOUN ct-9360 12 45 cell cell NOUN ct-9360 12 46 or or CCONJ ct-9360 12 47 t t NOUN ct-9360 12 48 cell cell NOUN ct-9360 12 49 lymphocytes lymphocyte VERB ct-9360 12 50 . . PUNCT ct-9360 13 1 immunophenotyping immunophenotype VERB ct-9360 13 2 is be AUX ct-9360 13 3 possible possible ADJ ct-9360 13 4 because because SCONJ ct-9360 13 5 b b X ct-9360 13 6 cell cell NOUN ct-9360 13 7 lymphomas lymphoma NOUN ct-9360 13 8 typically typically ADV ct-9360 13 9 express express VERB ct-9360 13 10 cell cell NOUN ct-9360 13 11 surface surface NOUN ct-9360 13 12 proteins protein NOUN ct-9360 13 13 cd79a cd79a NOUN ct-9360 13 14 , , PUNCT ct-9360 13 15 cd20 cd20 PROPN ct-9360 13 16 , , PUNCT ct-9360 13 17 cd21 cd21 PROPN ct-9360 13 18 , , PUNCT ct-9360 13 19 and and CCONJ ct-9360 13 20 pax5 pax5 PROPN ct-9360 13 21 , , PUNCT ct-9360 13 22 whereas whereas SCONJ ct-9360 13 23 t t NOUN ct-9360 13 24 cell cell NOUN ct-9360 13 25 lymphomas lymphoma NOUN ct-9360 13 26 typically typically ADV ct-9360 13 27 express express VERB ct-9360 13 28 the the DET ct-9360 13 29 unique unique ADJ ct-9360 13 30 cell cell NOUN ct-9360 13 31 surface surface NOUN ct-9360 13 32 protein protein NOUN ct-9360 13 33 cd3.3 cd3.3 NOUN ct-9360 13 34 symptoms symptom NOUN ct-9360 13 35 and and CCONJ ct-9360 13 36 treatment treatment NOUN ct-9360 13 37 options option NOUN ct-9360 13 38 vary vary VERB ct-9360 13 39 depending depend VERB ct-9360 13 40 on on ADP ct-9360 13 41 the the DET ct-9360 13 42 lymphoma lymphoma NOUN ct-9360 13 43 ’s ’s PART ct-9360 13 44 predominant predominant ADJ ct-9360 13 45 cell cell NOUN ct-9360 13 46 type type NOUN ct-9360 13 47 ( ( PUNCT ct-9360 13 48 i.e. i.e. X ct-9360 13 49 b b NOUN ct-9360 13 50 or or CCONJ ct-9360 13 51 t t NOUN ct-9360 13 52 cells).4 cells).4 PROPN ct-9360 13 53 although although SCONJ ct-9360 13 54 canine canine NOUN ct-9360 13 55 lymphoma lymphoma NOUN ct-9360 13 56 is be AUX ct-9360 13 57 typically typically ADV ct-9360 13 58 treated treat VERB ct-9360 13 59 by by ADP ct-9360 13 60 chemotherapy chemotherapy NOUN ct-9360 13 61 , , PUNCT ct-9360 13 62 b b X ct-9360 13 63 cell cell NOUN ct-9360 13 64 lymphomas lymphoma NOUN ct-9360 13 65 become become VERB ct-9360 13 66 resistant resistant ADJ ct-9360 13 67 to to ADP ct-9360 13 68 chemotherapy chemotherapy NOUN ct-9360 13 69 after after ADP ct-9360 13 70 subsequent subsequent ADJ ct-9360 13 71 treatments treatment NOUN ct-9360 13 72 and and CCONJ ct-9360 13 73 t t NOUN ct-9360 13 74 cell cell NOUN ct-9360 13 75 lymphomas lymphoma NOUN ct-9360 13 76 often often ADV ct-9360 13 77 do do AUX ct-9360 13 78 not not PART ct-9360 13 79 respond respond VERB ct-9360 13 80 well well ADV ct-9360 13 81 to to ADP ct-9360 13 82 chemotherapy chemotherapy NOUN ct-9360 13 83 from from ADP ct-9360 13 84 the the DET ct-9360 13 85 onset onset NOUN ct-9360 13 86 of of ADP ct-9360 13 87 treatment.5 treatment.5 NOUN ct-9360 13 88 prognosis prognosis NOUN ct-9360 13 89 following follow VERB ct-9360 13 90 diagnosis diagnosis NOUN ct-9360 13 91 with with ADP ct-9360 13 92 canine canine NOUN ct-9360 13 93 lymphoma lymphoma NOUN ct-9360 13 94 is be AUX ct-9360 13 95 also also ADV ct-9360 13 96 dependent dependent ADJ ct-9360 13 97 on on ADP ct-9360 13 98 the the DET ct-9360 13 99 immunophenotype immunophenotype NOUN ct-9360 13 100 of of ADP ct-9360 13 101 lymphoma lymphoma NOUN ct-9360 13 102 , , PUNCT ct-9360 13 103 with with ADP ct-9360 13 104 average average ADJ ct-9360 13 105 survival survival NOUN ct-9360 13 106 times time NOUN ct-9360 13 107 shorter short ADJ ct-9360 13 108 for for ADP ct-9360 13 109 t t NOUN ct-9360 13 110 cell cell NOUN ct-9360 13 111 than than ADP ct-9360 13 112 b b NOUN ct-9360 13 113 cell cell NOUN ct-9360 13 114 lymphomas lymphoma NOUN ct-9360 13 115 ( ( PUNCT ct-9360 13 116 183 183 NUM ct-9360 13 117 versus versus ADP ct-9360 13 118 365 365 NUM ct-9360 13 119 days).6 days).6 PROPN ct-9360 13 120 in in ADP ct-9360 13 121 general general ADJ ct-9360 13 122 , , PUNCT ct-9360 13 123 t t PROPN ct-9360 13 124 cell cell NOUN ct-9360 13 125 lymphomas lymphoma NOUN ct-9360 13 126 also also ADV ct-9360 13 127 have have VERB ct-9360 13 128 shorter short ADJ ct-9360 13 129 remissions remission NOUN ct-9360 13 130 than than SCONJ ct-9360 13 131 b b NOUN ct-9360 13 132 cell cell NOUN ct-9360 13 133 lymphomas.7 lymphomas.7 ADP ct-9360 13 134 - - SYM ct-9360 13 135 9 9 NUM ct-9360 13 136 basset basset NOUN ct-9360 13 137 hound hound NOUN ct-9360 13 138 , , PUNCT ct-9360 13 139 beagle beagle NOUN ct-9360 13 140 , , PUNCT ct-9360 13 141 bernese bernese ADJ ct-9360 13 142 mountain mountain NOUN ct-9360 13 143 dog dog NOUN ct-9360 13 144 , , PUNCT ct-9360 13 145 boxer boxer NOUN ct-9360 13 146 , , PUNCT ct-9360 13 147 bulldog bulldog NOUN ct-9360 13 148 , , PUNCT ct-9360 13 149 bull bull NOUN ct-9360 13 150 mastiff mastiff NOUN ct-9360 13 151 , , PUNCT ct-9360 13 152 cocker cocker NOUN ct-9360 13 153 spaniel spaniel NOUN ct-9360 13 154 , , PUNCT ct-9360 13 155 doberman doberman NOUN ct-9360 13 156 , , PUNCT ct-9360 13 157 german german ADJ ct-9360 13 158 shepherd shepherd NOUN ct-9360 13 159 , , PUNCT ct-9360 13 160 golden golden ADJ ct-9360 13 161 retriever retriever NOUN ct-9360 13 162 , , PUNCT ct-9360 13 163 labrador labrador NOUN ct-9360 13 164 retriever retriever NOUN ct-9360 13 165 , , PUNCT ct-9360 13 166 rottweiler rottweiler NOUN ct-9360 13 167 , , PUNCT ct-9360 13 168 shih shih PROPN ct-9360 13 169 tzu tzu PROPN ct-9360 13 170 , , PUNCT ct-9360 13 171 st st PROPN ct-9360 13 172 . . PROPN ct-9360 13 173 bernard bernard PROPN ct-9360 13 174 , , PUNCT ct-9360 13 175 and and CCONJ ct-9360 13 176 any any DET ct-9360 13 177 terrier terrier NOUN ct-9360 13 178 breed breed NOUN ct-9360 13 179 are be AUX ct-9360 13 180 at at ADP ct-9360 13 181 higher high ADJ ct-9360 13 182 risk risk NOUN ct-9360 13 183 for for ADP ct-9360 13 184 developing develop VERB ct-9360 13 185 lymphoma lymphoma NOUN ct-9360 13 186 , , PUNCT ct-9360 13 187 whereas whereas SCONJ ct-9360 13 188 dachshunds dachshund NOUN ct-9360 13 189 and and CCONJ ct-9360 13 190 pomeranians pomeranian NOUN ct-9360 13 191 are be AUX ct-9360 13 192 relatively relatively ADV ct-9360 13 193 lower low ADJ ct-9360 13 194 risk risk NOUN ct-9360 13 195 breeds.2,8,10,11 breeds.2,8,10,11 VERB ct-9360 13 196 additionally additionally ADV ct-9360 13 197 , , PUNCT ct-9360 13 198 breed breed NOUN ct-9360 13 199 appears appear VERB ct-9360 13 200 to to PART ct-9360 13 201 influence influence VERB ct-9360 13 202 the the DET ct-9360 13 203 lymphoma lymphoma NOUN ct-9360 13 204 immunophenotype immunophenotype NOUN ct-9360 13 205 . . PUNCT ct-9360 14 1 boxers boxer NOUN ct-9360 14 2 are be AUX ct-9360 14 3 more more ADV ct-9360 14 4 likely likely ADJ ct-9360 14 5 to to PART ct-9360 14 6 develop develop VERB ct-9360 14 7 t t NOUN ct-9360 14 8 cell cell NOUN ct-9360 14 9 lymphomas lymphoma NOUN ct-9360 14 10 , , PUNCT ct-9360 14 11 whereas whereas SCONJ ct-9360 14 12 basset basset VERB ct-9360 14 13 hounds hound NOUN ct-9360 14 14 and and CCONJ ct-9360 14 15 cocker cocker NOUN ct-9360 14 16 spaniels spaniel NOUN ct-9360 14 17 are be AUX ct-9360 14 18 more more ADV ct-9360 14 19 likely likely ADJ ct-9360 14 20 to to PART ct-9360 14 21 develop develop VERB ct-9360 14 22 b b NUM ct-9360 14 23 cell cell NOUN ct-9360 14 24 lymphomas.12 lymphomas.12 NOUN ct-9360 14 25 body body NOUN ct-9360 14 26 weight weight NOUN ct-9360 14 27 may may AUX ct-9360 14 28 or or CCONJ ct-9360 14 29 may may AUX ct-9360 14 30 not not PART ct-9360 14 31 be be AUX ct-9360 14 32 a a DET ct-9360 14 33 risk risk NOUN ct-9360 14 34 factor factor NOUN ct-9360 14 35 for for ADP ct-9360 14 36 lymphoma lymphoma NOUN ct-9360 14 37 . . PUNCT ct-9360 15 1 although although SCONJ ct-9360 15 2 body body NOUN ct-9360 15 3 weight weight NOUN ct-9360 15 4 in in ADP ct-9360 15 5 mixed mixed ADJ ct-9360 15 6 breed breed NOUN ct-9360 15 7 dogs dog NOUN ct-9360 15 8 had have VERB ct-9360 15 9 no no DET ct-9360 15 10 influence influence NOUN ct-9360 15 11 in in ADP ct-9360 15 12 lymphoma lymphoma NOUN ct-9360 15 13 occurrence,13 occurrence,13 NOUN ct-9360 15 14 it it PRON ct-9360 15 15 had have VERB ct-9360 15 16 an an DET ct-9360 15 17 influence influence NOUN ct-9360 15 18 in in ADP ct-9360 15 19 purebred purebre VERB ct-9360 15 20 dogs dog NOUN ct-9360 15 21 ; ; PUNCT ct-9360 15 22 9 9 NUM ct-9360 15 23 lymphomas lymphoma NOUN ct-9360 15 24 were be AUX ct-9360 15 25 more more ADV ct-9360 15 26 common common ADJ ct-9360 15 27 in in ADP ct-9360 15 28 medium medium ADJ ct-9360 15 29 and and CCONJ ct-9360 15 30 large large ADJ ct-9360 15 31 breed breed NOUN ct-9360 15 32 dogs dog NOUN ct-9360 15 33 compared compare VERB ct-9360 15 34 to to ADP ct-9360 15 35 toy toy NOUN ct-9360 15 36 and and CCONJ ct-9360 15 37 small small ADJ ct-9360 15 38 breed breed NOUN ct-9360 15 39 dogs.9 dogs.9 NOUN ct-9360 15 40 additionally additionally ADV ct-9360 15 41 , , PUNCT ct-9360 15 42 smaller small ADJ ct-9360 15 43 body body NOUN ct-9360 15 44 weight weight NOUN ct-9360 15 45 dogs dog NOUN ct-9360 15 46 ( ( PUNCT ct-9360 15 47 < < X ct-9360 15 48 17 17 NUM ct-9360 15 49 kg kg NOUN ct-9360 15 50 ) ) PUNCT ct-9360 15 51 were be AUX ct-9360 15 52 reported report VERB ct-9360 15 53 to to PART ct-9360 15 54 have have VERB ct-9360 15 55 longer long ADJ ct-9360 15 56 median median ADJ ct-9360 15 57 survival survival NOUN ct-9360 15 58 times14,15 times14,15 PROPN ct-9360 15 59 or or CCONJ ct-9360 15 60 no no DET ct-9360 15 61 difference difference NOUN ct-9360 15 62 in in ADP ct-9360 15 63 median median ADJ ct-9360 15 64 survival survival NOUN ct-9360 15 65 times1,16 times1,16 PUNCT ct-9360 15 66 when when SCONJ ct-9360 15 67 compared compare VERB ct-9360 15 68 to to ADP ct-9360 15 69 dogs dog NOUN ct-9360 15 70 with with ADP ct-9360 15 71 greater great ADJ ct-9360 15 72 body body NOUN ct-9360 15 73 weight weight NOUN ct-9360 15 74 . . PUNCT ct-9360 16 1 however however ADV ct-9360 16 2 , , PUNCT ct-9360 16 3 body body NOUN ct-9360 16 4 condition condition NOUN ct-9360 16 5 was be AUX ct-9360 16 6 not not PART ct-9360 16 7 reported report VERB ct-9360 16 8 in in ADP ct-9360 16 9 these these DET ct-9360 16 10 studies study NOUN ct-9360 16 11 . . PUNCT ct-9360 17 1 it it PRON ct-9360 17 2 is be AUX ct-9360 17 3 noteworthy noteworthy ADJ ct-9360 17 4 that that SCONJ ct-9360 17 5 dogs dog NOUN ct-9360 17 6 with with ADP ct-9360 17 7 an an DET ct-9360 17 8 underweight underweight NOUN ct-9360 17 9 body body NOUN ct-9360 17 10 condition condition NOUN ct-9360 17 11 had have VERB ct-9360 17 12 significantly significantly ADV ct-9360 17 13 shorter short ADJ ct-9360 17 14 survival survival NOUN ct-9360 17 15 times time NOUN ct-9360 17 16 than than SCONJ ct-9360 17 17 dogs dog NOUN ct-9360 17 18 in in ADP ct-9360 17 19 ideal ideal ADJ ct-9360 17 20 or or CCONJ ct-9360 17 21 overweight overweight ADJ ct-9360 17 22 body body NOUN ct-9360 17 23 condition.17 condition.17 PROPN ct-9360 17 24 survival survival NOUN ct-9360 17 25 from from ADP ct-9360 17 26 lymphoma lymphoma NOUN ct-9360 17 27 may may AUX ct-9360 17 28 be be AUX ct-9360 17 29 influenced influence VERB ct-9360 17 30 by by ADP ct-9360 17 31 sex sex NOUN ct-9360 17 32 . . PUNCT ct-9360 18 1 in in ADP ct-9360 18 2 humans human NOUN ct-9360 18 3 , , PUNCT ct-9360 18 4 men man NOUN ct-9360 18 5 generally generally ADV ct-9360 18 6 had have VERB ct-9360 18 7 shorter short ADJ ct-9360 18 8 survival survival NOUN ct-9360 18 9 times time NOUN ct-9360 18 10 than than ADP ct-9360 18 11 women woman NOUN ct-9360 18 12 for for ADP ct-9360 18 13 most most ADJ ct-9360 18 14 cancers cancer NOUN ct-9360 18 15 , , PUNCT ct-9360 18 16 including include VERB ct-9360 18 17 lymphoma.18 lymphoma.18 PROPN ct-9360 18 18 - - SYM ct-9360 18 19 20 20 NUM ct-9360 18 20 this this PRON ct-9360 18 21 is be AUX ct-9360 18 22 similar similar ADJ ct-9360 18 23 to to ADP ct-9360 18 24 what what PRON ct-9360 18 25 was be AUX ct-9360 18 26 clinical clinical ADJ ct-9360 18 27 theriogenology theriogenology NOUN ct-9360 19 1 • • NOUN ct-9360 19 2 volume volume NOUN ct-9360 19 3 13 13 NUM ct-9360 19 4 number number NOUN ct-9360 19 5 1 1 NUM ct-9360 19 6 • • NUM ct-9360 19 7 march march PROPN ct-9360 19 8 202137 202137 NUM ct-9360 19 9     SPACE ct-9360 19 10 observed observe VERB ct-9360 19 11 in in ADP ct-9360 19 12 dogs dog NOUN ct-9360 19 13 with with ADP ct-9360 19 14 advanced advanced ADJ ct-9360 19 15 multicentric multicentric ADJ ct-9360 19 16 lymphoma lymphoma NOUN ct-9360 19 17 ; ; PUNCT ct-9360 19 18 intact intact ADJ ct-9360 19 19 male male ADJ ct-9360 19 20 dogs dog NOUN ct-9360 19 21 had have VERB ct-9360 19 22 significantly significantly ADV ct-9360 19 23 shorter short ADJ ct-9360 19 24 remission remission NOUN ct-9360 19 25 and and CCONJ ct-9360 19 26 survival survival NOUN ct-9360 19 27 times time NOUN ct-9360 19 28 than than ADP ct-9360 19 29 intact intact ADJ ct-9360 19 30 female female ADJ ct-9360 19 31 dogs.10 dogs.10 NOUN ct-9360 19 32 luteinizing luteinizing NOUN ct-9360 19 33 hormone hormone NOUN ct-9360 19 34 receptors receptor NOUN ct-9360 19 35 ( ( PUNCT ct-9360 19 36 lhr lhr PROPN ct-9360 19 37 ) ) PUNCT ct-9360 19 38 are be AUX ct-9360 19 39 expressed express VERB ct-9360 19 40 in in ADP ct-9360 19 41 canine canine NOUN ct-9360 19 42 lymphoma lymphoma NOUN ct-9360 19 43 tissue tissue NOUN ct-9360 19 44 and and CCONJ ct-9360 19 45 isolated isolate VERB ct-9360 19 46 canine canine NOUN ct-9360 19 47 lymphoma lymphoma NOUN ct-9360 19 48 cells.21 cells.21 VERB ct-9360 19 49 however however ADV ct-9360 19 50 , , PUNCT ct-9360 19 51 the the DET ct-9360 19 52 influence influence NOUN ct-9360 19 53 of of ADP ct-9360 19 54 body body NOUN ct-9360 19 55 weight weight NOUN ct-9360 19 56 or or CCONJ ct-9360 19 57 sex sex NOUN ct-9360 19 58 on on ADP ct-9360 19 59 lhr lhr ADJ ct-9360 19 60 expression expression NOUN ct-9360 19 61 was be AUX ct-9360 19 62 not not PART ct-9360 19 63 evaluated evaluate VERB ct-9360 19 64 . . PUNCT ct-9360 20 1 additionally additionally ADV ct-9360 20 2 , , PUNCT ct-9360 20 3 the the DET ct-9360 20 4 influence influence NOUN ct-9360 20 5 of of ADP ct-9360 20 6 immunophenotype immunophenotype NOUN ct-9360 20 7 or or CCONJ ct-9360 20 8 tumor tumor NOUN ct-9360 20 9 stage stage NOUN ct-9360 20 10 on on ADP ct-9360 20 11 lhr lhr ADJ ct-9360 20 12 expression expression NOUN ct-9360 20 13 was be AUX ct-9360 20 14 also also ADV ct-9360 20 15 not not PART ct-9360 20 16 evaluated evaluate VERB ct-9360 20 17 . . PUNCT ct-9360 21 1 based base VERB ct-9360 21 2 on on ADP ct-9360 21 3 canine canine PROPN ct-9360 21 4 lymphoma lymphoma NOUN ct-9360 21 5 findings,6 findings,6 NOUN ct-9360 21 6 - - SYM ct-9360 21 7 10,14,15 10,14,15 NUM ct-9360 21 8 it it PRON ct-9360 21 9 was be AUX ct-9360 21 10 hypothesized hypothesize VERB ct-9360 21 11 that that SCONJ ct-9360 21 12 greater great ADJ ct-9360 21 13 body body NOUN ct-9360 21 14 weight weight NOUN ct-9360 21 15 male male ADJ ct-9360 21 16 dogs dog NOUN ct-9360 21 17 in in ADP ct-9360 21 18 advanced advanced ADJ ct-9360 21 19 tumor tumor NOUN ct-9360 21 20 stages stage NOUN ct-9360 21 21 with with ADP ct-9360 21 22 t t NOUN ct-9360 21 23 cell cell NOUN ct-9360 21 24 lymphomas lymphoma NOUN ct-9360 21 25 have have VERB ct-9360 21 26 higher high ADJ ct-9360 21 27 lhr lhr ADJ ct-9360 21 28 expression expression NOUN ct-9360 21 29 than than ADP ct-9360 21 30 lesser less ADJ ct-9360 21 31 body body NOUN ct-9360 21 32 weight weight NOUN ct-9360 21 33 female female ADJ ct-9360 21 34 dogs dog NOUN ct-9360 21 35 in in ADP ct-9360 21 36 earlier early ADJ ct-9360 21 37 tumor tumor NOUN ct-9360 21 38 stages stage NOUN ct-9360 21 39 with with ADP ct-9360 21 40 b b NOUN ct-9360 21 41 cell cell NOUN ct-9360 21 42 lymphomas lymphoma NOUN ct-9360 21 43 . . PUNCT ct-9360 22 1 materials material NOUN ct-9360 22 2 and and CCONJ ct-9360 22 3 methods method NOUN ct-9360 22 4 archived archive VERB ct-9360 22 5 tissue tissue NOUN ct-9360 22 6 samples sample NOUN ct-9360 22 7 ( ( PUNCT ct-9360 22 8 canine canine VERB ct-9360 22 9 comparative comparative ADJ ct-9360 22 10 oncology oncology NOUN ct-9360 22 11 and and CCONJ ct-9360 22 12 genomics genomic NOUN ct-9360 22 13 consortium consortium NOUN ct-9360 23 1 [ [ X ct-9360 23 2 bethesda bethesda PROPN ct-9360 23 3 , , PUNCT ct-9360 23 4 md md PROPN ct-9360 23 5 ] ] PUNCT ct-9360 23 6 ) ) PUNCT ct-9360 23 7 from from ADP ct-9360 23 8 40 40 NUM ct-9360 23 9 purebred purebre VERB ct-9360 23 10 and and CCONJ ct-9360 23 11 mixed mixed ADJ ct-9360 23 12 breed breed NOUN ct-9360 23 13 dogs dog NOUN ct-9360 23 14 ( ( PUNCT ct-9360 23 15 spayed spay VERB ct-9360 23 16 females female NOUN ct-9360 23 17 n n NOUN ct-9360 23 18 = = SYM ct-9360 23 19 24 24 NUM ct-9360 23 20 ; ; PUNCT ct-9360 23 21 neutered neuter VERB ct-9360 23 22 males male NOUN ct-9360 23 23 n n NOUN ct-9360 23 24 = = SYM ct-9360 23 25 16 16 NUM ct-9360 23 26 ) ) PUNCT ct-9360 23 27 weighing weigh VERB ct-9360 23 28 7 7 NUM ct-9360 23 29 56 56 NUM ct-9360 23 30 kg kg NOUN ct-9360 23 31 were be AUX ct-9360 23 32 used use VERB ct-9360 23 33 . . PUNCT ct-9360 24 1 weight weight NOUN ct-9360 24 2 categories category NOUN ct-9360 24 3 were be AUX ct-9360 24 4 similar similar ADJ ct-9360 24 5 to to ADP ct-9360 24 6 an an DET ct-9360 24 7 earlier early ADV ct-9360 24 8 study;13 study;13 ADJ ct-9360 24 9 < < X ct-9360 24 10 10 10 NUM ct-9360 24 11 kg kg NOUN ct-9360 24 12 ( ( PUNCT ct-9360 24 13 n n NOUN ct-9360 24 14 = = SYM ct-9360 24 15 4 4 NUM ct-9360 24 16 ) ) PUNCT ct-9360 24 17 , , PUNCT ct-9360 24 18 10 10 NUM ct-9360 24 19 19 19 NUM ct-9360 24 20 kg kg NOUN ct-9360 24 21 ( ( PUNCT ct-9360 24 22 n n NOUN ct-9360 24 23 = = SYM ct-9360 24 24 8) 8) NUM ct-9360 24 25 , , PUNCT ct-9360 24 26 20 20 NUM ct-9360 24 27 29 29 NUM ct-9360 24 28 kg kg NOUN ct-9360 24 29 ( ( PUNCT ct-9360 24 30 n n NOUN ct-9360 24 31 = = NOUN ct-9360 24 32 14 14 NUM ct-9360 24 33 ) ) PUNCT ct-9360 24 34 , , PUNCT ct-9360 24 35 30 30 NUM ct-9360 24 36 39 39 NUM ct-9360 24 37 kg kg NOUN ct-9360 24 38 ( ( PUNCT ct-9360 24 39 n n NOUN ct-9360 24 40 = = NUM ct-9360 24 41 10 10 NUM ct-9360 24 42 ) ) PUNCT ct-9360 24 43 , , PUNCT ct-9360 24 44 and and CCONJ ct-9360 24 45 > > X ct-9360 24 46 40 40 NUM ct-9360 24 47 kg kg NOUN ct-9360 24 48 ( ( PUNCT ct-9360 24 49 n n NOUN ct-9360 24 50 = = SYM ct-9360 24 51 4 4 NUM ct-9360 24 52 ) ) PUNCT ct-9360 24 53 . . PUNCT ct-9360 25 1 immunophenotype immunophenotype PROPN ct-9360 25 2 was be AUX ct-9360 25 3 available available ADJ ct-9360 25 4 for for ADP ct-9360 25 5 26 26 NUM ct-9360 25 6 of of ADP ct-9360 25 7 40 40 NUM ct-9360 25 8 tumors tumor NOUN ct-9360 25 9 ( ( PUNCT ct-9360 25 10 table table NOUN ct-9360 25 11 ) ) PUNCT ct-9360 25 12 . . PUNCT ct-9360 26 1 tumors tumor NOUN ct-9360 26 2 were be AUX ct-9360 26 3 staged stage VERB ct-9360 26 4 using use VERB ct-9360 26 5 the the DET ct-9360 26 6 world world NOUN ct-9360 26 7 health health NOUN ct-9360 26 8 organization organization NOUN ct-9360 26 9 system system NOUN ct-9360 26 10 : : PUNCT ct-9360 26 11 stage stage NOUN ct-9360 26 12 i i PRON ct-9360 26 13 , , PUNCT ct-9360 26 14 single single ADJ ct-9360 26 15 node node NOUN ct-9360 26 16 or or CCONJ ct-9360 26 17 lymphoid lymphoid ADJ ct-9360 26 18 tissue tissue NOUN ct-9360 26 19 in in ADP ct-9360 26 20 single single ADJ ct-9360 26 21 organ organ NOUN ct-9360 26 22 ; ; PUNCT ct-9360 26 23 stage stage NOUN ct-9360 26 24 ii ii PROPN ct-9360 26 25 , , PUNCT ct-9360 26 26 regional regional ADJ ct-9360 26 27 multiple multiple ADJ ct-9360 26 28 lymph lymph NOUN ct-9360 26 29 nodes node NOUN ct-9360 26 30 involvement involvement NOUN ct-9360 26 31 ; ; PUNCT ct-9360 26 32 stage stage NOUN ct-9360 26 33 iii iii PROPN ct-9360 26 34 , , PUNCT ct-9360 26 35 generalized generalized ADJ ct-9360 26 36 lymph lymph NOUN ct-9360 26 37 node node NOUN ct-9360 26 38 involvement involvement NOUN ct-9360 26 39 ; ; PUNCT ct-9360 26 40 stage stage NOUN ct-9360 26 41 iv iv NUM ct-9360 26 42 , , PUNCT ct-9360 26 43 stages stage NOUN ct-9360 26 44 i i NOUN ct-9360 26 45 iii iii VERB ct-9360 27 1 with with ADP ct-9360 27 2 liver liver NOUN ct-9360 27 3 and/or and/or CCONJ ct-9360 27 4 spleen spleen NOUN ct-9360 27 5 involvement involvement NOUN ct-9360 27 6 ; ; PUNCT ct-9360 27 7 and and CCONJ ct-9360 27 8 stage stage NOUN ct-9360 27 9 v v NOUN ct-9360 27 10 , , PUNCT ct-9360 27 11 stages stage NOUN ct-9360 27 12 i i PRON ct-9360 27 13 iv iv VERB ct-9360 27 14 with with ADP ct-9360 27 15 blood blood NOUN ct-9360 27 16 or or CCONJ ct-9360 27 17 bone bone NOUN ct-9360 27 18 marrow marrow NOUN ct-9360 27 19 involvement.21 involvement.21 NOUN ct-9360 27 20 additionally additionally ADV ct-9360 27 21 , , PUNCT ct-9360 27 22 samples sample NOUN ct-9360 27 23 from from ADP ct-9360 27 24 each each DET ct-9360 27 25 primary primary ADJ ct-9360 27 26 tumor tumor NOUN ct-9360 27 27 were be AUX ct-9360 27 28 formalin formalin NOUN ct-9360 27 29 - - PUNCT ct-9360 27 30 fixed fix VERB ct-9360 27 31 , , PUNCT ct-9360 27 32 paraffin paraffin NOUN ct-9360 27 33 - - PUNCT ct-9360 27 34 embedded embed VERB ct-9360 27 35 , , PUNCT ct-9360 27 36 and and CCONJ ct-9360 27 37 sectioned section VERB ct-9360 27 38 onto onto ADP ct-9360 27 39 charged charge VERB ct-9360 27 40 slides slide NOUN ct-9360 27 41 for for ADP ct-9360 27 42 lhr lhr ADJ ct-9360 27 43 immunohistochemistry immunohistochemistry NOUN ct-9360 27 44 . . PUNCT ct-9360 28 1 all all DET ct-9360 28 2 slides slide NOUN ct-9360 28 3 were be AUX ct-9360 28 4 deparaffinized deparaffinize VERB ct-9360 28 5 , , PUNCT ct-9360 28 6 rehydrated rehydrate VERB ct-9360 28 7 , , PUNCT ct-9360 28 8 subjected subject VERB ct-9360 28 9 to to ADP ct-9360 28 10 heat heat NOUN ct-9360 28 11 - - PUNCT ct-9360 28 12 induced induce VERB ct-9360 28 13 epitope epitope NOUN ct-9360 28 14 retrieval retrieval NOUN ct-9360 28 15 ( ( PUNCT ct-9360 28 16 # # SYM ct-9360 28 17 s1700 s1700 PROPN ct-9360 28 18 , , PUNCT ct-9360 28 19 dako dako PROPN ct-9360 28 20 , , PUNCT ct-9360 28 21 carpinteria carpinteria PROPN ct-9360 28 22 , , PUNCT ct-9360 28 23 ca ca NOUN ct-9360 28 24 ) ) PUNCT ct-9360 28 25 . . PUNCT ct-9360 29 1 endogenous endogenous ADJ ct-9360 29 2 peroxidase peroxidase NOUN ct-9360 29 3 activity activity NOUN ct-9360 29 4 was be AUX ct-9360 29 5 inactivated inactivate VERB ct-9360 29 6 with with ADP ct-9360 29 7 3 3 NUM ct-9360 29 8 % % NOUN ct-9360 29 9 hydrogen hydrogen NOUN ct-9360 29 10 peroxide peroxide NOUN ct-9360 29 11 and and CCONJ ct-9360 29 12 nonspecific nonspecific ADJ ct-9360 29 13 binding binding NOUN ct-9360 29 14 was be AUX ct-9360 29 15 blocked block VERB ct-9360 29 16 ( ( PUNCT ct-9360 29 17 protein protein NOUN ct-9360 29 18 block block NOUN ct-9360 29 19 serum serum NOUN ct-9360 29 20 - - PUNCT ct-9360 29 21 free free ADJ ct-9360 29 22 [ [ X ct-9360 29 23 # # NOUN ct-9360 29 24 x0909 x0909 ADJ ct-9360 29 25 , , PUNCT ct-9360 29 26 dako dako PROPN ct-9360 29 27 ] ] PUNCT ct-9360 29 28 ) ) PUNCT ct-9360 29 29 . . PUNCT ct-9360 30 1 either either CCONJ ct-9360 30 2 rabbit rabbit NOUN ct-9360 30 3 polyclonal polyclonal ADJ ct-9360 30 4 antihuman antihuman NOUN ct-9360 30 5 lhr lhr ADJ ct-9360 30 6 antibody antibody NOUN ct-9360 30 7 ( ( PUNCT ct-9360 30 8 # # NOUN ct-9360 30 9 nls1436 nls1436 NOUN ct-9360 30 10 , , PUNCT ct-9360 30 11 novus novus NOUN ct-9360 30 12 biologics biologic NOUN ct-9360 30 13 , , PUNCT ct-9360 30 14 centennial centennial NOUN ct-9360 30 15 , , PUNCT ct-9360 30 16 co co NOUN ct-9360 30 17 ) ) PUNCT ct-9360 30 18 was be AUX ct-9360 30 19 applied apply VERB ct-9360 30 20 at at ADP ct-9360 30 21 1:100 1:100 NUM ct-9360 30 22 dilution dilution NOUN ct-9360 30 23 or or CCONJ ct-9360 30 24 rabbit rabbit NOUN ct-9360 30 25 negative negative ADJ ct-9360 30 26 control control NOUN ct-9360 30 27 ( ( PUNCT ct-9360 30 28 # # SYM ct-9360 30 29 nc495h nc495h NOUN ct-9360 30 30 , , PUNCT ct-9360 30 31 biocare biocare PROPN ct-9360 30 32 medical medical PROPN ct-9360 30 33 , , PUNCT ct-9360 30 34 pacheco pacheco PROPN ct-9360 30 35 , , PUNCT ct-9360 30 36 ca ca NOUN ct-9360 30 37 ) ) PUNCT ct-9360 30 38 was be AUX ct-9360 30 39 applied apply VERB ct-9360 30 40 to to ADP ct-9360 30 41 slides slide NOUN ct-9360 30 42 . . PUNCT ct-9360 31 1 this this DET ct-9360 31 2 antigen antigen ADJ ct-9360 31 3 retrieval retrieval NOUN ct-9360 31 4 method method NOUN ct-9360 31 5 and and CCONJ ct-9360 31 6 antibody antibody NOUN ct-9360 31 7 concentration concentration NOUN ct-9360 31 8 were be AUX ct-9360 31 9 optimal optimal ADJ ct-9360 31 10 for for SCONJ ct-9360 31 11 normal normal ADJ ct-9360 31 12 and and CCONJ ct-9360 31 13 neoplastic neoplastic ADJ ct-9360 31 14 canine canine NOUN ct-9360 31 15 lymphatic lymphatic ADJ ct-9360 31 16 tissue.21 tissue.21 NOUN ct-9360 31 17 slides slide NOUN ct-9360 31 18 were be AUX ct-9360 31 19 treated treat VERB ct-9360 31 20 with with ADP ct-9360 31 21 one one NUM ct-9360 31 22 step step NOUN ct-9360 31 23 horse horse NOUN ct-9360 31 24 radish radish NOUN ct-9360 31 25 peroxidaseconjugated peroxidaseconjugate VERB ct-9360 31 26 polymer polymer NOUN ct-9360 31 27 antirabbit antirabbit NOUN ct-9360 31 28 igg igg PROPN ct-9360 31 29 ( ( PUNCT ct-9360 31 30 # # SYM ct-9360 31 31 ih-8064 ih-8064 ADJ ct-9360 31 32 - - PUNCT ct-9360 31 33 custom custom NOUN ct-9360 31 34 - - PUNCT ct-9360 31 35 orsu orsu ADJ ct-9360 31 36 , , PUNCT ct-9360 31 37 immunobioscience immunobioscience NOUN ct-9360 31 38 , , PUNCT ct-9360 31 39 mukilteo mukilteo PROPN ct-9360 31 40 , , PUNCT ct-9360 31 41 wa wa PROPN ct-9360 31 42 ) ) PUNCT ct-9360 31 43 , , PUNCT ct-9360 31 44 followed follow VERB ct-9360 31 45 by by ADP ct-9360 31 46 nova nova PROPN ct-9360 31 47 red red ADJ ct-9360 31 48 peroxidase peroxidase NOUN ct-9360 31 49 substrate substrate NOUN ct-9360 31 50 ( ( PUNCT ct-9360 31 51 # # ADJ ct-9360 31 52 sk4800 sk4800 NOUN ct-9360 31 53 , , PUNCT ct-9360 31 54 vector vector NOUN ct-9360 31 55 laboratories laboratory NOUN ct-9360 31 56 , , PUNCT ct-9360 31 57 burlingame burlingame PROPN ct-9360 31 58 , , PUNCT ct-9360 31 59 ca ca NOUN ct-9360 31 60 ) ) PUNCT ct-9360 31 61 . . PUNCT ct-9360 32 1 slides slide NOUN ct-9360 32 2 were be AUX ct-9360 32 3 counter counter ADJ ct-9360 32 4 - - VERB ct-9360 32 5 stained stained ADJ ct-9360 32 6 with with ADP ct-9360 32 7 hematoxylin hematoxylin NOUN ct-9360 32 8 , , PUNCT ct-9360 32 9 dehydrated dehydrate VERB ct-9360 32 10 , , PUNCT ct-9360 32 11 and and CCONJ ct-9360 32 12 mounted mount VERB ct-9360 32 13 . . PUNCT ct-9360 33 1 percentage percentage NOUN ct-9360 33 2 of of ADP ct-9360 33 3 cells cell NOUN ct-9360 33 4 positive positive ADJ ct-9360 33 5 for for ADP ct-9360 33 6 lhr lhr PROPN ct-9360 33 7 was be AUX ct-9360 33 8 recorded record VERB ct-9360 33 9 and and CCONJ ct-9360 33 10 staining stain VERB ct-9360 33 11 intensity intensity NOUN ct-9360 33 12 ( ( PUNCT ct-9360 33 13 scored score VERB ct-9360 33 14 0 0 NUM ct-9360 33 15 3 3 NUM ct-9360 33 16 ; ; PUNCT ct-9360 33 17 figure figure NOUN ct-9360 33 18 1 1 NUM ct-9360 33 19 ) ) PUNCT ct-9360 33 20 was be AUX ct-9360 33 21 determined determine VERB ct-9360 33 22 at at ADP ct-9360 33 23 400 400 NUM ct-9360 33 24 x x NOUN ct-9360 33 25 magnification magnification NOUN ct-9360 33 26 from from ADP ct-9360 33 27 5 5 NUM ct-9360 33 28 randomly randomly ADV ct-9360 33 29 selected select VERB ct-9360 33 30 fields field NOUN ct-9360 33 31 by by ADP ct-9360 33 32 1 1 NUM ct-9360 33 33 person person NOUN ct-9360 33 34 ( ( PUNCT ct-9360 33 35 av av NOUN ct-9360 33 36 ) ) PUNCT ct-9360 33 37 blinded blind VERB ct-9360 33 38 to to ADP ct-9360 33 39 the the DET ct-9360 33 40 identity identity NOUN ct-9360 33 41 of of ADP ct-9360 33 42 the the DET ct-9360 33 43 samples sample NOUN ct-9360 33 44 . . PUNCT ct-9360 34 1 additionally additionally ADV ct-9360 34 2 , , PUNCT ct-9360 34 3 a a DET ct-9360 34 4 histology histology NOUN ct-9360 34 5 score score NOUN ct-9360 34 6 ( ( PUNCT ct-9360 34 7 h h NOUN ct-9360 34 8 - - PUNCT ct-9360 34 9 score score NOUN ct-9360 34 10 ) ) PUNCT ct-9360 34 11 was be AUX ct-9360 34 12 assigned assign VERB ct-9360 34 13 to to ADP ct-9360 34 14 each each DET ct-9360 34 15 tumor tumor NOUN ct-9360 34 16 sample.23,24 sample.23,24 VERB ct-9360 34 17 staining stain VERB ct-9360 34 18 intensity intensity NOUN ct-9360 34 19 ( ( PUNCT ct-9360 34 20 0 0 NUM ct-9360 34 21 3 3 NUM ct-9360 34 22 ) ) PUNCT ct-9360 34 23 for for SCONJ ct-9360 34 24 a a DET ct-9360 34 25 fixed fix VERB ct-9360 34 26 field field NOUN ct-9360 34 27 was be AUX ct-9360 34 28 multiplied multiply VERB ct-9360 34 29 by by ADP ct-9360 34 30 the the DET ct-9360 34 31 percentage percentage NOUN ct-9360 34 32 of of ADP ct-9360 34 33 cell cell NOUN ct-9360 34 34 positive positive ADJ ct-9360 34 35 for for ADP ct-9360 34 36 lhr lhr PROPN ct-9360 34 37 . . PUNCT ct-9360 35 1 differences difference NOUN ct-9360 35 2 between between ADP ct-9360 35 3 sex sex NOUN ct-9360 35 4 and and CCONJ ct-9360 35 5 tumor tumor NOUN ct-9360 35 6 phenotype phenotype NOUN ct-9360 35 7 were be AUX ct-9360 35 8 compared compare VERB ct-9360 35 9 ( ( PUNCT ct-9360 35 10 welch welch PROPN ct-9360 35 11 two two NUM ct-9360 35 12 sample sample NOUN ct-9360 35 13 t t NOUN ct-9360 35 14 - - PUNCT ct-9360 35 15 test test NOUN ct-9360 35 16 in in ADP ct-9360 35 17 the the DET ct-9360 35 18 free free ADJ ct-9360 35 19 statistical statistical ADJ ct-9360 35 20 package package NOUN ct-9360 36 1 r r NOUN ct-9360 37 1 [ [ X ct-9360 37 2 version version NOUN ct-9360 37 3 1.2.1355 1.2.1355 NUM ct-9360 37 4 , , PUNCT ct-9360 37 5 boston boston PROPN ct-9360 37 6 , , PUNCT ct-9360 37 7 ma ma PROPN ct-9360 37 8 ] ] NOUN ct-9360 37 9 ) ) PUNCT ct-9360 37 10 . . PUNCT ct-9360 38 1 differences difference NOUN ct-9360 38 2 in in ADP ct-9360 38 3 bodyweight bodyweight NOUN ct-9360 38 4 and and CCONJ ct-9360 38 5 tumor tumor NOUN ct-9360 38 6 stage stage NOUN ct-9360 38 7 were be AUX ct-9360 38 8 compared compare VERB ct-9360 38 9 ( ( PUNCT ct-9360 38 10 simple simple ADJ ct-9360 38 11 linear linear ADJ ct-9360 38 12 regression regression NOUN ct-9360 38 13 [ [ X ct-9360 38 14 microsoft microsoft PROPN ct-9360 38 15 excel excel VERB ct-9360 38 16 , , PUNCT ct-9360 38 17 version version NOUN ct-9360 38 18 14.5.2 14.5.2 NUM ct-9360 38 19 , , PUNCT ct-9360 38 20 redmond redmond PROPN ct-9360 38 21 , , PUNCT ct-9360 38 22 wa wa NOUN ct-9360 38 23 ] ] NOUN ct-9360 38 24 ) ) PUNCT ct-9360 38 25 . . PUNCT ct-9360 39 1 additionally additionally ADV ct-9360 39 2 , , PUNCT ct-9360 39 3 differences difference NOUN ct-9360 39 4 in in ADP ct-9360 39 5 body body NOUN ct-9360 39 6 weight weight NOUN ct-9360 39 7 group group NOUN ct-9360 39 8 were be AUX ct-9360 39 9 compared compare VERB ct-9360 39 10 ( ( PUNCT ct-9360 39 11 one one NUM ct-9360 39 12 - - PUNCT ct-9360 39 13 way way NOUN ct-9360 39 14 anova anova PROPN ct-9360 39 15 ) ) PUNCT ct-9360 39 16 . . PUNCT ct-9360 40 1 data datum NOUN ct-9360 40 2 were be AUX ct-9360 40 3 expressed express VERB ct-9360 40 4 as as ADP ct-9360 40 5 mean mean NOUN ct-9360 40 6 ± ± NUM ct-9360 40 7 standard standard ADJ ct-9360 40 8 deviation deviation NOUN ct-9360 40 9 and and CCONJ ct-9360 40 10 significance significance NOUN ct-9360 40 11 was be AUX ct-9360 40 12 defined define VERB ct-9360 40 13 as as ADP ct-9360 40 14 p p X ct-9360 40 15 < < X ct-9360 40 16 0.05 0.05 NUM ct-9360 40 17 . . PUNCT ct-9360 40 18 results result NOUN ct-9360 40 19 although although SCONJ ct-9360 40 20 there there PRON ct-9360 40 21 were be VERB ct-9360 40 22 many many ADJ ct-9360 40 23 purebred purebre VERB ct-9360 40 24 dogs dog NOUN ct-9360 40 25 included include VERB ct-9360 40 26 in in ADP ct-9360 40 27 the the DET ct-9360 40 28 data datum NOUN ct-9360 40 29 set set VERB ct-9360 40 30 , , PUNCT ct-9360 40 31 mixed mixed ADJ ct-9360 40 32 breed breed NOUN ct-9360 40 33 dogs dog NOUN ct-9360 40 34 were be AUX ct-9360 40 35 overrepresented overrepresente VERB ct-9360 40 36 ( ( PUNCT ct-9360 40 37 table table NOUN ct-9360 40 38 ) ) PUNCT ct-9360 40 39 . . PUNCT ct-9360 41 1 most most ADJ ct-9360 41 2 breeds breed NOUN ct-9360 41 3 were be AUX ct-9360 41 4 only only ADV ct-9360 41 5 represented represent VERB ct-9360 41 6 by by ADP ct-9360 41 7 1 1 NUM ct-9360 41 8 individual individual NOUN ct-9360 41 9 , , PUNCT ct-9360 41 10 except except SCONJ ct-9360 41 11 labrador labrador NOUN ct-9360 41 12 retrievers retriever NOUN ct-9360 41 13 ( ( PUNCT ct-9360 41 14 n n NOUN ct-9360 41 15 = = SYM ct-9360 41 16 3 3 NUM ct-9360 41 17 ) ) PUNCT ct-9360 41 18 , , PUNCT ct-9360 41 19 german german ADJ ct-9360 41 20 shorthaired shorthaire VERB ct-9360 41 21 pointers pointer NOUN ct-9360 41 22 ( ( PUNCT ct-9360 41 23 n n NOUN ct-9360 41 24 = = SYM ct-9360 41 25 2 2 NUM ct-9360 41 26 ) ) PUNCT ct-9360 41 27 , , PUNCT ct-9360 41 28 poodles poodle NOUN ct-9360 41 29 ( ( PUNCT ct-9360 41 30 n n NOUN ct-9360 41 31 = = SYM ct-9360 41 32 2 2 NUM ct-9360 41 33 ) ) PUNCT ct-9360 41 34 , , PUNCT ct-9360 41 35 miniature miniature ADJ ct-9360 41 36 schnauzers schnauzer NOUN ct-9360 41 37 ( ( PUNCT ct-9360 41 38 n n NOUN ct-9360 41 39 = = SYM ct-9360 41 40 2 2 NUM ct-9360 41 41 ) ) PUNCT ct-9360 41 42 , , PUNCT ct-9360 41 43 and and CCONJ ct-9360 41 44 boston boston PROPN ct-9360 41 45 terriers terrier NOUN ct-9360 41 46 ( ( PUNCT ct-9360 41 47 n n NOUN ct-9360 41 48 = = SYM ct-9360 41 49 2 2 NUM ct-9360 41 50 ) ) PUNCT ct-9360 41 51 . . PUNCT ct-9360 42 1 irrespective irrespective ADV ct-9360 42 2 of of ADP ct-9360 42 3 breed breed NOUN ct-9360 42 4 , , PUNCT ct-9360 42 5 all all DET ct-9360 42 6 lymphoma lymphoma NOUN ct-9360 42 7 tissue tissue NOUN ct-9360 42 8 samples sample NOUN ct-9360 42 9 contained contain VERB ct-9360 42 10 cells cell NOUN ct-9360 42 11 positive positive ADJ ct-9360 42 12 for for ADP ct-9360 42 13 lhr lhr PROPN ct-9360 42 14 . . PUNCT ct-9360 43 1 however however ADV ct-9360 43 2 , , PUNCT ct-9360 43 3 percentage percentage NOUN ct-9360 43 4 of of ADP ct-9360 43 5 cellular cellular ADJ ct-9360 43 6 expression expression NOUN ct-9360 43 7 and and CCONJ ct-9360 43 8 staining stain VERB ct-9360 43 9 intensity intensity NOUN ct-9360 43 10 varied varied ADJ ct-9360 43 11 among among ADP ct-9360 43 12 individuals individual NOUN ct-9360 43 13 ( ( PUNCT ct-9360 43 14 figure figure NOUN ct-9360 43 15 1 1 NUM ct-9360 43 16 ) ) PUNCT ct-9360 43 17 . . PUNCT ct-9360 44 1 body body NOUN ct-9360 44 2 weight weight NOUN ct-9360 44 3 had have VERB ct-9360 44 4 no no DET ct-9360 44 5 significant significant ADJ ct-9360 44 6 influence influence NOUN ct-9360 44 7 and and CCONJ ct-9360 44 8 there there PRON ct-9360 44 9 was be VERB ct-9360 44 10 no no DET ct-9360 44 11 significant significant ADJ ct-9360 44 12 association association NOUN ct-9360 44 13 between between ADP ct-9360 44 14 the the DET ct-9360 44 15 percentage percentage NOUN ct-9360 44 16 of of ADP ct-9360 44 17 lhr lhr ADJ ct-9360 44 18 positive positive ADJ ct-9360 44 19 cells cell NOUN ct-9360 44 20 ( ( PUNCT ct-9360 44 21 r2 r2 PROPN ct-9360 44 22 = = PROPN ct-9360 44 23 0.021 0.021 NUM ct-9360 44 24 ) ) PUNCT ct-9360 44 25 or or CCONJ ct-9360 44 26 staining stain VERB ct-9360 44 27 intensity intensity NOUN ct-9360 44 28 ( ( PUNCT ct-9360 44 29 r2 r2 PROPN ct-9360 44 30 = = NOUN ct-9360 44 31 0.077 0.077 NUM ct-9360 44 32 ) ) PUNCT ct-9360 44 33 . . PUNCT ct-9360 45 1 there there PRON ct-9360 45 2 were be VERB ct-9360 45 3 also also ADV ct-9360 45 4 no no DET ct-9360 45 5 significant significant ADJ ct-9360 45 6 differences difference NOUN ct-9360 45 7 in in ADP ct-9360 45 8 the the DET ct-9360 45 9 percentage percentage NOUN ct-9360 45 10 of of ADP ct-9360 45 11 lhr lhr ADJ ct-9360 45 12 positive positive ADJ ct-9360 45 13 cells cell NOUN ct-9360 45 14 , , PUNCT ct-9360 45 15 staining stain VERB ct-9360 45 16 intensity intensity NOUN ct-9360 45 17 or or CCONJ ct-9360 45 18 h h NOUN ct-9360 45 19 - - PUNCT ct-9360 45 20 score score NOUN ct-9360 45 21 when when SCONJ ct-9360 45 22 compared compare VERB ct-9360 45 23 by by ADP ct-9360 45 24 sex sex NOUN ct-9360 45 25 ( ( PUNCT ct-9360 45 26 figure figure NOUN ct-9360 45 27 2 2 NUM ct-9360 45 28 ) ) PUNCT ct-9360 45 29 or or CCONJ ct-9360 45 30 lymphoma lymphoma NOUN ct-9360 45 31 phenotype phenotype NOUN ct-9360 45 32 ( ( PUNCT ct-9360 45 33 figure figure NOUN ct-9360 45 34 3 3 NUM ct-9360 45 35 ) ) PUNCT ct-9360 45 36 . . PUNCT ct-9360 46 1 there there PRON ct-9360 46 2 was be VERB ct-9360 46 3 no no DET ct-9360 46 4 significant significant ADJ ct-9360 46 5 association association NOUN ct-9360 46 6 between between ADP ct-9360 46 7 the the DET ct-9360 46 8 percentage percentage NOUN ct-9360 46 9 of of ADP ct-9360 46 10 lhr lhr ADJ ct-9360 46 11 positive positive ADJ ct-9360 46 12 cells cell NOUN ct-9360 46 13 ( ( PUNCT ct-9360 46 14 r2 r2 PROPN ct-9360 46 15 = = PUNCT ct-9360 46 16 0.0017 0.0017 NUM ct-9360 46 17 ) ) PUNCT ct-9360 46 18 or or CCONJ ct-9360 46 19 staining stain VERB ct-9360 46 20 intensity intensity NOUN ct-9360 46 21 ( ( PUNCT ct-9360 46 22 r2 r2 PROPN ct-9360 46 23 = = SYM ct-9360 46 24 0.063 0.063 NUM ct-9360 46 25 ) ) PUNCT ct-9360 46 26 with with ADP ct-9360 46 27 regard regard NOUN ct-9360 46 28 to to ADP ct-9360 46 29 tumor tumor NOUN ct-9360 46 30 stage stage NOUN ct-9360 46 31 . . PUNCT ct-9360 47 1 clinical clinical ADJ ct-9360 47 2 theriogenology theriogenology NOUN ct-9360 47 3 • • NOUN ct-9360 47 4 volume volume NOUN ct-9360 47 5 13 13 NUM ct-9360 47 6 number number NOUN ct-9360 47 7 1 1 NUM ct-9360 47 8 • • NUM ct-9360 47 9 march march NOUN ct-9360 47 10 2021 2021 NUM ct-9360 47 11 38 38 NUM ct-9360 47 12     SPACE ct-9360 47 13 table table NOUN ct-9360 47 14 . . PUNCT ct-9360 48 1 gonadectomized gonadectomize VERB ct-9360 48 2 dogs dog NOUN ct-9360 48 3 with with ADP ct-9360 48 4 lymphoma lymphoma NOUN ct-9360 48 5 studied study VERB ct-9360 48 6 : : PUNCT ct-9360 48 7 body body NOUN ct-9360 48 8 weight weight NOUN ct-9360 48 9 , , PUNCT ct-9360 48 10 sex sex NOUN ct-9360 48 11 , , PUNCT ct-9360 48 12 tumor tumor NOUN ct-9360 48 13 phenotype phenotype NOUN ct-9360 48 14 , , PUNCT ct-9360 48 15 tumor tumor NOUN ct-9360 48 16 stage stage NOUN ct-9360 48 17 on on ADP ct-9360 48 18 the the DET ct-9360 48 19 percentage percentage NOUN ct-9360 48 20 of of ADP ct-9360 48 21 lhr lhr ADJ ct-9360 48 22 positive positive ADJ ct-9360 48 23 cells cell NOUN ct-9360 48 24 , , PUNCT ct-9360 48 25 staining stain VERB ct-9360 48 26 intensity intensity NOUN ct-9360 48 27 , , PUNCT ct-9360 48 28 and and CCONJ ct-9360 48 29 histology histology NOUN ct-9360 48 30 score score NOUN ct-9360 48 31 ( ( PUNCT ct-9360 48 32 h h NOUN ct-9360 48 33 - - PUNCT ct-9360 48 34 score score NOUN ct-9360 48 35 ) ) PUNCT ct-9360 48 36 female female NOUN ct-9360 48 37 ( ( PUNCT ct-9360 48 38 f f NOUN ct-9360 48 39 ) ) PUNCT ct-9360 48 40 ; ; PUNCT ct-9360 48 41 male male NOUN ct-9360 48 42 ( ( PUNCT ct-9360 48 43 m m NOUN ct-9360 48 44 ) ) PUNCT ct-9360 48 45 ; ; PUNCT ct-9360 48 46 not not PART ct-9360 48 47 available available ADJ ct-9360 48 48 ( ( PUNCT ct-9360 48 49 na na NOUN ct-9360 48 50 ) ) PUNCT ct-9360 48 51 i i PROPN ct-9360 48 52 d d PROPN ct-9360 48 53 breed breed PROPN ct-9360 48 54 sex sex NOUN ct-9360 48 55 weight weight NOUN ct-9360 48 56 ( ( PUNCT ct-9360 48 57 kg kg NOUN ct-9360 48 58 ) ) PUNCT ct-9360 48 59 tumor tumor NOUN ct-9360 48 60 phenotype phenotype NOUN ct-9360 48 61 tumor tumor NOUN ct-9360 48 62 stage stage NOUN ct-9360 48 63 percent percent NOUN ct-9360 48 64 positive positive ADJ ct-9360 48 65 staining staining ADJ ct-9360 48 66 intensity intensity NOUN ct-9360 48 67 h h NOUN ct-9360 48 68 - - PUNCT ct-9360 48 69 score score NOUN ct-9360 48 70 5678 5678 NUM ct-9360 48 71 miniature miniature NOUN ct-9360 48 72 schnauzer schnauzer NOUN ct-9360 48 73 f f PROPN ct-9360 48 74 7 7 NUM ct-9360 48 75 na na PART ct-9360 48 76 3 3 NUM ct-9360 48 77 10 10 NUM ct-9360 48 78 2.5 2.5 NUM ct-9360 48 79 25 25 NUM ct-9360 48 80 5682 5682 NUM ct-9360 48 81 shih shih NOUN ct-9360 48 82 tzu tzu PROPN ct-9360 48 83 f f PROPN ct-9360 48 84 7.2 7.2 NUM ct-9360 48 85 na na PART ct-9360 48 86 5 5 NUM ct-9360 48 87 10.5 10.5 NUM ct-9360 48 88 1 1 NUM ct-9360 48 89 10.5 10.5 NUM ct-9360 48 90 5656 5656 NUM ct-9360 48 91 boston boston PROPN ct-9360 48 92 terrier terrier PROPN ct-9360 48 93 f f PROPN ct-9360 48 94 8 8 NUM ct-9360 48 95 na na PART ct-9360 48 96 2 2 NUM ct-9360 48 97 10.5 10.5 NUM ct-9360 48 98 3 3 NUM ct-9360 48 99 31.5 31.5 NUM ct-9360 48 100 5664 5664 NUM ct-9360 48 101 pembroke pembroke PROPN ct-9360 48 102 welsh welsh PROPN ct-9360 48 103 corgi corgi PROPN ct-9360 48 104 f f PROPN ct-9360 48 105 9.5 9.5 NUM ct-9360 48 106 na na PART ct-9360 48 107 3 3 NUM ct-9360 48 108 6.8 6.8 NUM ct-9360 48 109 3 3 NUM ct-9360 48 110 20.4 20.4 NUM ct-9360 48 111 5676 5676 NUM ct-9360 48 112 miniature miniature NOUN ct-9360 48 113 schnauzer schnauzer NOUN ct-9360 48 114 f f PROPN ct-9360 49 1 11.4 11.4 NUM ct-9360 49 2 na na NOUN ct-9360 49 3 3 3 NUM ct-9360 49 4 3 3 NUM ct-9360 49 5 2.5 2.5 NUM ct-9360 49 6 7.5 7.5 NUM ct-9360 49 7 5698 5698 NUM ct-9360 49 8 shetland shetland NOUN ct-9360 49 9 sheepdog sheepdog NOUN ct-9360 49 10 f f PROPN ct-9360 50 1 12.6 12.6 NUM ct-9360 50 2 b b PROPN ct-9360 50 3 cell cell NOUN ct-9360 50 4 3 3 NUM ct-9360 50 5 23.5 23.5 NUM ct-9360 50 6 3 3 NUM ct-9360 50 7 70.5 70.5 NUM ct-9360 50 8 5707 5707 NUM ct-9360 50 9 cocker cocker NOUN ct-9360 50 10 spaniel spaniel NOUN ct-9360 50 11 f f PROPN ct-9360 50 12 14 14 NUM ct-9360 50 13 t t NOUN ct-9360 50 14 cell cell NOUN ct-9360 50 15 3 3 NUM ct-9360 50 16 10.3 10.3 NUM ct-9360 50 17 3 3 NUM ct-9360 50 18 30.7 30.7 NUM ct-9360 50 19 5657 5657 NUM ct-9360 50 20 poodle poodle NOUN ct-9360 50 21 m m VERB ct-9360 50 22 15.2 15.2 NUM ct-9360 50 23 b b NOUN ct-9360 50 24 cell cell NOUN ct-9360 50 25 5 5 NUM ct-9360 50 26 5.75 5.75 NUM ct-9360 50 27 2.5 2.5 NUM ct-9360 50 28 14.4 14.4 NUM ct-9360 50 29 5702 5702 NUM ct-9360 50 30 boston boston PROPN ct-9360 50 31 terrier terrier PROPN ct-9360 50 32 m m VERB ct-9360 50 33 16 16 NUM ct-9360 50 34 b b NOUN ct-9360 50 35 cell cell NOUN ct-9360 50 36 3 3 NUM ct-9360 50 37 20 20 NUM ct-9360 50 38 2 2 NUM ct-9360 50 39 40 40 NUM ct-9360 50 40 5675 5675 NUM ct-9360 50 41 mixed mixed ADJ ct-9360 50 42 breed breed NOUN ct-9360 50 43 f f PROPN ct-9360 50 44 17.3 17.3 NUM ct-9360 50 45 na na PART ct-9360 50 46 5 5 NUM ct-9360 50 47 16.6 16.6 NUM ct-9360 50 48 2 2 NUM ct-9360 50 49 33.2 33.2 NUM ct-9360 50 50 5666 5666 NUM ct-9360 50 51 vizsla vizsla PROPN ct-9360 50 52 f f PROPN ct-9360 50 53 19 19 NUM ct-9360 50 54 b b PROPN ct-9360 50 55 cell cell NOUN ct-9360 50 56 3 3 NUM ct-9360 50 57 20.8 20.8 NUM ct-9360 50 58 1.5 1.5 NUM ct-9360 50 59 31.2 31.2 NUM ct-9360 50 60 5713 5713 NUM ct-9360 50 61 mixed mixed ADJ ct-9360 50 62 breed breed NOUN ct-9360 50 63 f f PROPN ct-9360 50 64 19.7 19.7 NUM ct-9360 50 65 na na NOUN ct-9360 50 66 3 3 NUM ct-9360 50 67 7.5 7.5 NUM ct-9360 50 68 3 3 NUM ct-9360 50 69 22.5 22.5 NUM ct-9360 50 70 5689 5689 NUM ct-9360 50 71 labrador labrador NOUN ct-9360 50 72 retriever retriever PROPN ct-9360 50 73 f f PROPN ct-9360 50 74 21 21 NUM ct-9360 50 75 t t NOUN ct-9360 50 76 cell cell NOUN ct-9360 50 77 5 5 NUM ct-9360 50 78 7.5 7.5 NUM ct-9360 50 79 2 2 NUM ct-9360 50 80 15 15 NUM ct-9360 50 81 5715 5715 NUM ct-9360 50 82 mixed mix VERB ct-9360 50 83 breed breed NOUN ct-9360 50 84 m m PROPN ct-9360 50 85 21.4 21.4 NUM ct-9360 50 86 b b NOUN ct-9360 50 87 cell cell NOUN ct-9360 50 88 3 3 NUM ct-9360 50 89 3 3 NUM ct-9360 50 90 2 2 NUM ct-9360 50 91 6 6 NUM ct-9360 50 92 5709 5709 NUM ct-9360 50 93 poodle poodle NOUN ct-9360 50 94 f f PROPN ct-9360 50 95 22 22 NUM ct-9360 50 96 b b PROPN ct-9360 50 97 cell cell NOUN ct-9360 50 98 4 4 NUM ct-9360 50 99 3.6 3.6 NUM ct-9360 50 100 2 2 NUM ct-9360 50 101 7.2 7.2 NUM ct-9360 50 102 5708 5708 NUM ct-9360 50 103 mixed mix VERB ct-9360 50 104 breed breed NOUN ct-9360 50 105 f f PROPN ct-9360 50 106 22.6 22.6 NUM ct-9360 50 107 b b PROPN ct-9360 50 108 cell cell NOUN ct-9360 50 109 3 3 NUM ct-9360 50 110 9 9 NUM ct-9360 50 111 2.5 2.5 NUM ct-9360 50 112 22.5 22.5 NUM ct-9360 50 113 5662 5662 NUM ct-9360 50 114 german german ADJ ct-9360 50 115 shorthair shorthair NOUN ct-9360 50 116 pointer pointer NOUN ct-9360 50 117 f f PROPN ct-9360 50 118 24.5 24.5 NUM ct-9360 50 119 na na PART ct-9360 50 120 4 4 NUM ct-9360 50 121 10.8 10.8 NUM ct-9360 50 122 3 3 NUM ct-9360 50 123 32.4 32.4 NUM ct-9360 50 124 5672 5672 NUM ct-9360 50 125 german german ADJ ct-9360 50 126 shorthair shorthair NOUN ct-9360 50 127 pointer pointer NOUN ct-9360 50 128 f f PROPN ct-9360 50 129 26 26 NUM ct-9360 50 130 na na PART ct-9360 50 131 4 4 NUM ct-9360 50 132 9.5 9.5 NUM ct-9360 50 133 2 2 NUM ct-9360 50 134 19 19 NUM ct-9360 50 135 5681 5681 NUM ct-9360 50 136 mixed mixed ADJ ct-9360 50 137 breed breed NOUN ct-9360 50 138 m m PROPN ct-9360 50 139 26 26 NUM ct-9360 50 140 b b NOUN ct-9360 50 141 cell cell NOUN ct-9360 50 142 4 4 NUM ct-9360 50 143 21.8 21.8 NUM ct-9360 50 144 2 2 NUM ct-9360 50 145 43.6 43.6 NUM ct-9360 50 146 5655 5655 NUM ct-9360 50 147 samoyed samoye VERB ct-9360 50 148 f f PROPN ct-9360 51 1 26.7 26.7 NUM ct-9360 51 2 na na PART ct-9360 51 3 2 2 NUM ct-9360 51 4 17.65 17.65 NUM ct-9360 51 5 3 3 NUM ct-9360 51 6 52.9 52.9 NUM ct-9360 51 7 5691 5691 NUM ct-9360 51 8 boxer boxer NOUN ct-9360 51 9 m m VERB ct-9360 51 10 28.6 28.6 NUM ct-9360 51 11 t t NOUN ct-9360 51 12 cell cell NOUN ct-9360 51 13 3 3 NUM ct-9360 51 14 15 15 NUM ct-9360 51 15 2 2 NUM ct-9360 51 16 30 30 NUM ct-9360 51 17 5659 5659 NUM ct-9360 51 18 labrador labrador NOUN ct-9360 51 19 retriever retriever NOUN ct-9360 51 20 f f PROPN ct-9360 52 1 28.6 28.6 NUM ct-9360 52 2 na na PART ct-9360 52 3 2 2 NUM ct-9360 52 4 19 19 NUM ct-9360 52 5 2 2 NUM ct-9360 52 6 38 38 NUM ct-9360 52 7 5710 5710 NUM ct-9360 52 8 mixed mixed ADJ ct-9360 52 9 breed breed NOUN ct-9360 52 10 f f PROPN ct-9360 52 11 28.8 28.8 NUM ct-9360 52 12 b b PROPN ct-9360 52 13 cell cell NOUN ct-9360 52 14 3 3 NUM ct-9360 52 15 6.5 6.5 NUM ct-9360 52 16 2 2 NUM ct-9360 52 17 13 13 NUM ct-9360 52 18 5684 5684 NUM ct-9360 52 19 dalmatian dalmatian PROPN ct-9360 52 20 m m PROPN ct-9360 52 21 29 29 NUM ct-9360 52 22 b b PROPN ct-9360 52 23 cell cell NOUN ct-9360 52 24 3 3 NUM ct-9360 52 25 9 9 NUM ct-9360 52 26 2 2 NUM ct-9360 52 27 18 18 NUM ct-9360 52 28 5714 5714 NUM ct-9360 52 29 mixed mix VERB ct-9360 52 30 breed breed NOUN ct-9360 52 31 m m PROPN ct-9360 52 32 29.3 29.3 NUM ct-9360 52 33 b b NOUN ct-9360 52 34 cell cell NOUN ct-9360 52 35 4 4 NUM ct-9360 52 36 2 2 NUM ct-9360 52 37 1.5 1.5 NUM ct-9360 52 38 3 3 NUM ct-9360 52 39 5720 5720 NUM ct-9360 52 40 mixed mix VERB ct-9360 52 41 breed breed NOUN ct-9360 52 42 m m PROPN ct-9360 52 43 29.5 29.5 NUM ct-9360 52 44 b b NOUN ct-9360 52 45 cell cell NOUN ct-9360 52 46 4 4 NUM ct-9360 52 47 10 10 NUM ct-9360 52 48 1.5 1.5 NUM ct-9360 52 49 15 15 NUM ct-9360 52 50 5694 5694 NUM ct-9360 52 51 bernese bernese ADJ ct-9360 52 52 mountain mountain NOUN ct-9360 52 53 dog dog NOUN ct-9360 52 54 m m VERB ct-9360 52 55 30 30 NUM ct-9360 52 56 t t NOUN ct-9360 52 57 cell cell NOUN ct-9360 52 58 3 3 NUM ct-9360 52 59 4.3 4.3 NUM ct-9360 52 60 1.5 1.5 NUM ct-9360 52 61 6.4 6.4 NUM ct-9360 52 62 5660 5660 NUM ct-9360 52 63 labrador labrador NOUN ct-9360 52 64 retriever retriever PROPN ct-9360 52 65 f f PROPN ct-9360 52 66 30 30 NUM ct-9360 52 67 t t NOUN ct-9360 52 68 cell cell NOUN ct-9360 52 69 5 5 NUM ct-9360 52 70 5.9 5.9 NUM ct-9360 52 71 2 2 NUM ct-9360 52 72 11.8 11.8 NUM ct-9360 52 73 5668 5668 NUM ct-9360 52 74 mixed mixed ADJ ct-9360 52 75 breed breed NOUN ct-9360 52 76 m m PROPN ct-9360 52 77 31.6 31.6 NUM ct-9360 52 78 b b NOUN ct-9360 52 79 cell cell NOUN ct-9360 52 80 4 4 NUM ct-9360 52 81 13.4 13.4 NUM ct-9360 52 82 2 2 NUM ct-9360 52 83 26.8 26.8 NUM ct-9360 52 84 5690 5690 NUM ct-9360 52 85 mixed mix VERB ct-9360 52 86 breed breed NOUN ct-9360 52 87 m m PROPN ct-9360 52 88 32 32 NUM ct-9360 52 89 b b NOUN ct-9360 52 90 cell cell NOUN ct-9360 52 91 3 3 NUM ct-9360 52 92 7.8 7.8 NUM ct-9360 52 93 2 2 NUM ct-9360 52 94 15.6 15.6 NUM ct-9360 52 95 5667 5667 NUM ct-9360 52 96 basset basset VERB ct-9360 52 97 hound hound NOUN ct-9360 52 98 f f PROPN ct-9360 52 99 34.6 34.6 NUM ct-9360 52 100 na na PART ct-9360 52 101 3 3 NUM ct-9360 52 102 8.2 8.2 NUM ct-9360 52 103 3 3 NUM ct-9360 52 104 24.6 24.6 NUM ct-9360 52 105 5658 5658 NUM ct-9360 52 106 australian australian ADJ ct-9360 52 107 shepherd shepherd NOUN ct-9360 52 108 m m PROPN ct-9360 52 109 35.2 35.2 NUM ct-9360 52 110 t t NOUN ct-9360 52 111 cell cell NOUN ct-9360 52 112 5 5 NUM ct-9360 52 113 10.3 10.3 NUM ct-9360 52 114 2 2 NUM ct-9360 52 115 20.6 20.6 NUM ct-9360 52 116 5688 5688 NUM ct-9360 52 117 mixed mix VERB ct-9360 52 118 breed breed NOUN ct-9360 52 119 m m PROPN ct-9360 52 120 35.2 35.2 NUM ct-9360 52 121 b b NOUN ct-9360 52 122 cell cell NOUN ct-9360 52 123 3 3 NUM ct-9360 52 124 10 10 NUM ct-9360 52 125 1 1 NUM ct-9360 52 126 10 10 NUM ct-9360 52 127 5671 5671 NUM ct-9360 52 128 mixed mix VERB ct-9360 52 129 breed breed NOUN ct-9360 52 130 f f PROPN ct-9360 52 131 37.2 37.2 NUM ct-9360 52 132 b b NOUN ct-9360 52 133 cell cell NOUN ct-9360 52 134 4 4 NUM ct-9360 52 135 5 5 NUM ct-9360 52 136 3 3 NUM ct-9360 52 137 15 15 NUM ct-9360 52 138 5706 5706 NUM ct-9360 52 139 black black ADJ ct-9360 52 140 / / SYM ct-9360 52 141 tan tan PROPN ct-9360 52 142 coonhound coonhound NOUN ct-9360 52 143 f f PROPN ct-9360 52 144 37.5 37.5 NUM ct-9360 52 145 na na PART ct-9360 52 146 3 3 NUM ct-9360 52 147 3.6 3.6 NUM ct-9360 52 148 2 2 NUM ct-9360 52 149 7.2 7.2 NUM ct-9360 52 150 5704 5704 NUM ct-9360 52 151 mixed mixed ADJ ct-9360 52 152 breed breed NOUN ct-9360 52 153 f f PROPN ct-9360 52 154 38 38 NUM ct-9360 52 155 b b PROPN ct-9360 52 156 cell cell NOUN ct-9360 52 157 4 4 NUM ct-9360 52 158 26.5 26.5 NUM ct-9360 52 159 0.5 0.5 NUM ct-9360 52 160 13.2 13.2 NUM ct-9360 52 161 5685 5685 NUM ct-9360 52 162 irish irish ADJ ct-9360 52 163 setter setter NOUN ct-9360 52 164 m m PROPN ct-9360 52 165 46.5 46.5 NUM ct-9360 52 166 b b PROPN ct-9360 52 167 cell cell NOUN ct-9360 52 168 4 4 NUM ct-9360 52 169 7 7 NUM ct-9360 52 170 3 3 NUM ct-9360 52 171 21 21 NUM ct-9360 52 172 5703 5703 NUM ct-9360 52 173 mixed mixed ADJ ct-9360 52 174 breed breed NOUN ct-9360 52 175 m m PROPN ct-9360 52 176 50 50 NUM ct-9360 52 177 b b NOUN ct-9360 52 178 cell cell NOUN ct-9360 52 179 3 3 NUM ct-9360 52 180 8 8 NUM ct-9360 52 181 2 2 NUM ct-9360 52 182 16 16 NUM ct-9360 52 183 5680 5680 NUM ct-9360 52 184 bullmastiff bullmastiff NOUN ct-9360 52 185 f f PROPN ct-9360 52 186 52 52 NUM ct-9360 52 187 b b PROPN ct-9360 52 188 cell cell NOUN ct-9360 52 189 5 5 NUM ct-9360 52 190 7.3 7.3 NUM ct-9360 52 191 0.5 0.5 NUM ct-9360 52 192 3.6 3.6 NUM ct-9360 52 193 5705 5705 NUM ct-9360 52 194 saint saint PROPN ct-9360 52 195 bernard bernard PROPN ct-9360 52 196 m m PROPN ct-9360 52 197 56 56 NUM ct-9360 52 198 na na PART ct-9360 52 199 5 5 NUM ct-9360 52 200 6.3 6.3 NUM ct-9360 52 201 2.5 2.5 NUM ct-9360 52 202 15.6 15.6 NUM ct-9360 52 203 clinical clinical ADJ ct-9360 52 204 theriogenology theriogenology NOUN ct-9360 52 205 • • NOUN ct-9360 52 206 volume volume NOUN ct-9360 52 207 13 13 NUM ct-9360 52 208 number number NOUN ct-9360 52 209 1 1 NUM ct-9360 52 210 • • NUM ct-9360 52 211 march march PROPN ct-9360 52 212 202139 202139 NUM ct-9360 52 213 figure figure NOUN ct-9360 52 214 1 1 NUM ct-9360 52 215 . . PUNCT ct-9360 52 216 representative representative ADJ ct-9360 52 217 images image NOUN ct-9360 52 218 for for ADP ct-9360 52 219 luteinizing luteinize VERB ct-9360 52 220 hormone hormone NOUN ct-9360 52 221 receptors receptor NOUN ct-9360 52 222 staining stain VERB ct-9360 52 223 intensity intensity NOUN ct-9360 52 224 in in ADP ct-9360 52 225 canine canine NOUN ct-9360 52 226 lymphoma lymphoma NOUN ct-9360 52 227 ( ( PUNCT ct-9360 52 228 a a DET ct-9360 52 229 : : PUNCT ct-9360 52 230 staining stain VERB ct-9360 52 231 intensity intensity NOUN ct-9360 52 232 = = NOUN ct-9360 52 233 1 1 NUM ct-9360 52 234 ; ; PUNCT ct-9360 52 235 b b NUM ct-9360 52 236 : : PUNCT ct-9360 52 237 staining stain VERB ct-9360 52 238 intensity intensity NOUN ct-9360 52 239 = = SYM ct-9360 52 240 2 2 NUM ct-9360 52 241 ; ; PUNCT ct-9360 52 242 c c X ct-9360 52 243 : : PUNCT ct-9360 52 244 staining stain VERB ct-9360 52 245 intensity intensity NOUN ct-9360 52 246 = = NOUN ct-9360 52 247 3 3 NUM ct-9360 52 248 ) ) PUNCT ct-9360 52 249 . . PUNCT ct-9360 53 1 nova nova PROPN ct-9360 53 2 red red PROPN ct-9360 53 3 ; ; PUNCT ct-9360 53 4 bar bar NOUN ct-9360 53 5 = = PUNCT ct-9360 53 6 10 10 NUM ct-9360 53 7 μm μm NOUN ct-9360 53 8 . . PUNCT ct-9360 53 9 negative negative ADJ ct-9360 53 10 control control NOUN ct-9360 53 11 in in ADP ct-9360 53 12 upper upper ADJ ct-9360 53 13 right right ADJ ct-9360 53 14 inset inset NOUN ct-9360 53 15 . . PUNCT ct-9360 54 1 arrows arrow NOUN ct-9360 54 2 illustrate illustrate VERB ct-9360 54 3 examples example NOUN ct-9360 54 4 of of ADP ct-9360 54 5 cells cell NOUN ct-9360 54 6 stained stain VERB ct-9360 54 7 positive positive ADJ ct-9360 54 8 . . PUNCT ct-9360 55 1 40 40 NUM ct-9360 55 2     SPACE ct-9360 55 3 clinical clinical ADJ ct-9360 55 4 theriogenology theriogenology NOUN ct-9360 55 5 • • NOUN ct-9360 55 6 volume volume NOUN ct-9360 55 7 13 13 NUM ct-9360 55 8 number number NOUN ct-9360 55 9 1 1 NUM ct-9360 55 10 • • NUM ct-9360 55 11 march march NOUN ct-9360 55 12 2021 2021 NUM ct-9360 55 13     SPACE ct-9360 55 14 figure figure NOUN ct-9360 55 15 2 2 NUM ct-9360 55 16 . . PUNCT ct-9360 55 17 effect effect NOUN ct-9360 55 18 of of ADP ct-9360 55 19 sex sex NOUN ct-9360 55 20 ( ( PUNCT ct-9360 55 21 neutered neuter VERB ct-9360 55 22 male male NOUN ct-9360 55 23 versus versus ADP ct-9360 55 24 spayed spay VERB ct-9360 55 25 female female NOUN ct-9360 55 26 ) ) PUNCT ct-9360 55 27 on on ADP ct-9360 55 28 luteinizing luteinize VERB ct-9360 55 29 hormone hormone NOUN ct-9360 55 30 receptor receptor NOUN ct-9360 55 31 ( ( PUNCT ct-9360 55 32 lhr lhr NOUN ct-9360 55 33 ) ) PUNCT ct-9360 55 34 staining stain VERB ct-9360 55 35 intensity intensity NOUN ct-9360 55 36 ( ( PUNCT ct-9360 55 37 a a X ct-9360 55 38 ) ) PUNCT ct-9360 55 39 , , PUNCT ct-9360 55 40 percentage percentage NOUN ct-9360 55 41 of of ADP ct-9360 55 42 positive positive ADJ ct-9360 55 43 cells cell NOUN ct-9360 55 44 ( ( PUNCT ct-9360 55 45 b b NOUN ct-9360 55 46 ) ) PUNCT ct-9360 55 47 , , PUNCT ct-9360 55 48 and and CCONJ ct-9360 55 49 h h NOUN ct-9360 55 50 - - PUNCT ct-9360 55 51 score score NOUN ct-9360 55 52 ( ( PUNCT ct-9360 55 53 c c NOUN ct-9360 55 54 ) ) PUNCT ct-9360 55 55 . . PUNCT ct-9360 56 1 there there PRON ct-9360 56 2 was be VERB ct-9360 56 3 no no DET ct-9360 56 4 significant significant ADJ ct-9360 56 5 effect effect NOUN ct-9360 56 6 of of ADP ct-9360 56 7 sex sex NOUN ct-9360 56 8 on on ADP ct-9360 56 9 lhr lhr ADJ ct-9360 56 10 expression expression NOUN ct-9360 56 11 ( ( PUNCT ct-9360 56 12 p p X ct-9360 56 13 > > X ct-9360 56 14 0.05 0.05 NUM ct-9360 56 15 ) ) PUNCT ct-9360 56 16 . . PUNCT ct-9360 57 1 figure figure VERB ct-9360 57 2 3 3 NUM ct-9360 57 3 . . PUNCT ct-9360 57 4 effect effect NOUN ct-9360 57 5 of of ADP ct-9360 57 6 lymphoma lymphoma NOUN ct-9360 57 7 phenotype phenotype NOUN ct-9360 57 8 ( ( PUNCT ct-9360 57 9 b b NOUN ct-9360 57 10 cell cell NOUN ct-9360 57 11 versus versus ADP ct-9360 57 12 t t NOUN ct-9360 57 13 cell cell NOUN ct-9360 57 14 ) ) PUNCT ct-9360 57 15 on on ADP ct-9360 57 16 luteinizing luteinize VERB ct-9360 57 17 hormone hormone NOUN ct-9360 57 18 receptor receptor NOUN ct-9360 57 19 ( ( PUNCT ct-9360 57 20 lhr lhr NOUN ct-9360 57 21 ) ) PUNCT ct-9360 57 22 staining stain VERB ct-9360 57 23 intensity intensity NOUN ct-9360 57 24 ( ( PUNCT ct-9360 57 25 a a NOUN ct-9360 57 26 ) ) PUNCT ct-9360 57 27 and and CCONJ ct-9360 57 28 percentage percentage NOUN ct-9360 57 29 of of ADP ct-9360 57 30 positive positive ADJ ct-9360 57 31 cells cell NOUN ct-9360 57 32 ( ( PUNCT ct-9360 57 33 b b NOUN ct-9360 57 34 ) ) PUNCT ct-9360 57 35 , , PUNCT ct-9360 57 36 and and CCONJ ct-9360 57 37 h h NOUN ct-9360 57 38 - - PUNCT ct-9360 57 39 score score NOUN ct-9360 57 40 ( ( PUNCT ct-9360 57 41 c c NOUN ct-9360 57 42 ) ) PUNCT ct-9360 57 43 . . PUNCT ct-9360 58 1 there there PRON ct-9360 58 2 was be VERB ct-9360 58 3 no no DET ct-9360 58 4 significant significant ADJ ct-9360 58 5 effect effect NOUN ct-9360 58 6 of of ADP ct-9360 58 7 phenotype phenotype NOUN ct-9360 58 8 on on ADP ct-9360 58 9 lhr lhr ADJ ct-9360 58 10 expression expression NOUN ct-9360 58 11 ( ( PUNCT ct-9360 58 12 p p X ct-9360 58 13 > > X ct-9360 58 14 0.05 0.05 NUM ct-9360 58 15 ) ) PUNCT ct-9360 58 16 . . PUNCT ct-9360 59 1 clinical clinical ADJ ct-9360 59 2 theriogenology theriogenology NOUN ct-9360 59 3 • • NOUN ct-9360 59 4 volume volume NOUN ct-9360 59 5 13 13 NUM ct-9360 59 6 number number NOUN ct-9360 59 7 1 1 NUM ct-9360 59 8 • • NUM ct-9360 59 9 march march PROPN ct-9360 59 10 202141 202141 NUM ct-9360 59 11     SPACE ct-9360 59 12 discussion discussion NOUN ct-9360 59 13 certain certain ADJ ct-9360 59 14 breeds breed NOUN ct-9360 59 15 are be AUX ct-9360 59 16 predisposed predispose VERB ct-9360 59 17 to to ADP ct-9360 59 18 developing develop VERB ct-9360 59 19 lymphoma.2,8 lymphoma.2,8 PROPN ct-9360 59 20 - - PUNCT ct-9360 59 21 12,25 12,25 PROPN ct-9360 59 22 since since SCONJ ct-9360 59 23 there there PRON ct-9360 59 24 were be VERB ct-9360 59 25 not not PART ct-9360 59 26 enough enough ADJ ct-9360 59 27 dogs dog NOUN ct-9360 59 28 represented represent VERB ct-9360 59 29 by by ADP ct-9360 59 30 any any DET ct-9360 59 31 single single ADJ ct-9360 59 32 breed breed NOUN ct-9360 59 33 in in ADP ct-9360 59 34 the the DET ct-9360 59 35 current current ADJ ct-9360 59 36 study study NOUN ct-9360 59 37 to to PART ct-9360 59 38 compare compare VERB ct-9360 59 39 the the DET ct-9360 59 40 expression expression NOUN ct-9360 59 41 of of ADP ct-9360 59 42 lhr lhr PROPN ct-9360 59 43 , , PUNCT ct-9360 59 44 the the DET ct-9360 59 45 effect effect NOUN ct-9360 59 46 of of ADP ct-9360 59 47 body body NOUN ct-9360 59 48 weight weight NOUN ct-9360 59 49 was be AUX ct-9360 59 50 examined examine VERB ct-9360 59 51 . . PUNCT ct-9360 60 1 in in ADP ct-9360 60 2 agreement agreement NOUN ct-9360 60 3 with with ADP ct-9360 60 4 previous previous ADJ ct-9360 60 5 research research NOUN ct-9360 60 6 on on ADP ct-9360 60 7 lhr lhr ADJ ct-9360 60 8 expression expression NOUN ct-9360 60 9 in in ADP ct-9360 60 10 the the DET ct-9360 60 11 bladder,26 bladder,26 NOUN ct-9360 60 12 body body NOUN ct-9360 60 13 weight weight NOUN ct-9360 60 14 did do AUX ct-9360 60 15 not not PART ct-9360 60 16 influence influence VERB ct-9360 60 17 lhr lhr ADJ ct-9360 60 18 expression expression NOUN ct-9360 60 19 in in ADP ct-9360 60 20 canine canine NOUN ct-9360 60 21 lymphoma lymphoma NOUN ct-9360 60 22 . . PUNCT ct-9360 61 1 it it PRON ct-9360 61 2 is be AUX ct-9360 61 3 important important ADJ ct-9360 61 4 to to PART ct-9360 61 5 note note VERB ct-9360 61 6 that that SCONJ ct-9360 61 7 body body NOUN ct-9360 61 8 condition condition NOUN ct-9360 61 9 score score NOUN ct-9360 61 10 was be AUX ct-9360 61 11 not not PART ct-9360 61 12 available available ADJ ct-9360 61 13 in in ADP ct-9360 61 14 the the DET ct-9360 61 15 current current ADJ ct-9360 61 16 study study NOUN ct-9360 61 17 , , PUNCT ct-9360 61 18 which which PRON ct-9360 61 19 could could AUX ct-9360 61 20 have have AUX ct-9360 61 21 been be AUX ct-9360 61 22 a a DET ct-9360 61 23 confounding confound VERB ct-9360 61 24 factor factor NOUN ct-9360 61 25 , , PUNCT ct-9360 61 26 since since SCONJ ct-9360 61 27 underweight underweight NOUN ct-9360 61 28 dogs dog NOUN ct-9360 61 29 with with ADP ct-9360 61 30 lymphoma lymphoma NOUN ct-9360 61 31 were be AUX ct-9360 61 32 reported report VERB ct-9360 61 33 to to PART ct-9360 61 34 have have VERB ct-9360 61 35 significantly significantly ADV ct-9360 61 36 shorter short ADJ ct-9360 61 37 survival survival NOUN ct-9360 61 38 times.17 times.17 PROPN ct-9360 61 39 sex sex NOUN ct-9360 61 40 had have VERB ct-9360 61 41 a a DET ct-9360 61 42 role role NOUN ct-9360 61 43 in in ADP ct-9360 61 44 remission remission NOUN ct-9360 61 45 and and CCONJ ct-9360 61 46 survival survival PROPN ct-9360 61 47 times time NOUN ct-9360 61 48 following follow VERB ct-9360 61 49 lymphoma lymphoma NOUN ct-9360 61 50 diagnosis.1,9,16,27 diagnosis.1,9,16,27 PROPN ct-9360 61 51 therefore therefore ADV ct-9360 61 52 , , PUNCT ct-9360 61 53 we we PRON ct-9360 61 54 sought seek VERB ct-9360 61 55 to to PART ct-9360 61 56 determine determine VERB ct-9360 61 57 if if SCONJ ct-9360 61 58 lhr lhr ADJ ct-9360 61 59 expression expression NOUN ct-9360 61 60 in in ADP ct-9360 61 61 canine canine NOUN ct-9360 61 62 lymphoma lymphoma NOUN ct-9360 61 63 differed differ VERB ct-9360 61 64 by by ADP ct-9360 61 65 sex sex NOUN ct-9360 61 66 . . PUNCT ct-9360 62 1 although although SCONJ ct-9360 62 2 there there PRON ct-9360 62 3 was be VERB ct-9360 62 4 no no DET ct-9360 62 5 significant significant ADJ ct-9360 62 6 influence influence NOUN ct-9360 62 7 of of ADP ct-9360 62 8 sex sex NOUN ct-9360 62 9 on on ADP ct-9360 62 10 lhr lhr ADJ ct-9360 62 11 expression expression NOUN ct-9360 62 12 , , PUNCT ct-9360 62 13 it it PRON ct-9360 62 14 is be AUX ct-9360 62 15 noteworthy noteworthy ADJ ct-9360 62 16 that that SCONJ ct-9360 62 17 the the DET ct-9360 62 18 case case NOUN ct-9360 62 19 material material NOUN ct-9360 62 20 available available ADJ ct-9360 62 21 for for ADP ct-9360 62 22 this this DET ct-9360 62 23 study study NOUN ct-9360 62 24 was be AUX ct-9360 62 25 unfortunately unfortunately ADV ct-9360 62 26 limited limited ADJ ct-9360 62 27 to to PART ct-9360 62 28 only only ADV ct-9360 62 29 spayed spay VERB ct-9360 62 30 and and CCONJ ct-9360 62 31 neutered neuter VERB ct-9360 62 32 dogs dog NOUN ct-9360 62 33 ; ; PUNCT ct-9360 62 34 these these DET ct-9360 62 35 dogs dog NOUN ct-9360 62 36 may may AUX ct-9360 62 37 have have VERB ct-9360 62 38 an an DET ct-9360 62 39 increased increase VERB ct-9360 62 40 risk risk NOUN ct-9360 62 41 of of ADP ct-9360 62 42 developing develop VERB ct-9360 62 43 lymphoma lymphoma NOUN ct-9360 62 44 , , PUNCT ct-9360 62 45 depending depend VERB ct-9360 62 46 on on ADP ct-9360 62 47 their their PRON ct-9360 62 48 breed.25 breed.25 NOUN ct-9360 62 49 compared compare VERB ct-9360 62 50 to to ADP ct-9360 62 51 intact intact ADJ ct-9360 62 52 females female NOUN ct-9360 62 53 and and CCONJ ct-9360 62 54 males male NOUN ct-9360 62 55 , , PUNCT ct-9360 62 56 lymphoma lymphoma NOUN ct-9360 62 57 is be AUX ct-9360 62 58 4 4 NUM ct-9360 62 59 times time NOUN ct-9360 62 60 more more ADV ct-9360 62 61 common common ADJ ct-9360 62 62 in in ADP ct-9360 62 63 spayed spay VERB ct-9360 62 64 and and CCONJ ct-9360 62 65 neutered neutered ADJ ct-9360 62 66 viszlas.28 viszlas.28 NOUN ct-9360 62 67 occurrence occurrence NOUN ct-9360 62 68 of of ADP ct-9360 62 69 lymphoma lymphoma NOUN ct-9360 62 70 was be AUX ct-9360 62 71 higher high ADJ ct-9360 62 72 in in ADP ct-9360 62 73 spayed spay VERB ct-9360 62 74 than than ADP ct-9360 62 75 intact intact ADJ ct-9360 62 76 females female NOUN ct-9360 62 77 . . PUNCT ct-9360 63 1 10 10 NUM ct-9360 63 2 absence absence NOUN ct-9360 63 3 of of ADP ct-9360 63 4 gonadal gonadal ADJ ct-9360 63 5 hormones hormone NOUN ct-9360 63 6 in in ADP ct-9360 63 7 the the DET ct-9360 63 8 dogs dog NOUN ct-9360 63 9 sampled sample VERB ct-9360 63 10 for for ADP ct-9360 63 11 the the DET ct-9360 63 12 current current ADJ ct-9360 63 13 study study NOUN ct-9360 63 14 may may AUX ct-9360 63 15 have have VERB ct-9360 63 16 masked mask VERB ct-9360 63 17 effects effect NOUN ct-9360 63 18 of of ADP ct-9360 63 19 sex sex NOUN ct-9360 63 20 on on ADP ct-9360 63 21 lhr lhr ADJ ct-9360 63 22 expression expression NOUN ct-9360 63 23 . . PUNCT ct-9360 64 1 further further ADJ ct-9360 64 2 research research NOUN ct-9360 64 3 is be AUX ct-9360 64 4 needed need VERB ct-9360 64 5 on on ADP ct-9360 64 6 susceptible susceptible ADJ ct-9360 64 7 breeds breed NOUN ct-9360 64 8 to to PART ct-9360 64 9 determine determine VERB ct-9360 64 10 if if SCONJ ct-9360 64 11 lhr lhr ADJ ct-9360 64 12 expression expression NOUN ct-9360 64 13 within within ADP ct-9360 64 14 lymphoma lymphoma NOUN ct-9360 64 15 tissue tissue NOUN ct-9360 64 16 is be AUX ct-9360 64 17 increased increase VERB ct-9360 64 18 in in ADP ct-9360 64 19 gonadectomized gonadectomize VERB ct-9360 64 20 compared compare VERB ct-9360 64 21 to to ADP ct-9360 64 22 intact intact ADJ ct-9360 64 23 dogs dog NOUN ct-9360 64 24 . . PUNCT ct-9360 65 1 lymphoma lymphoma NOUN ct-9360 65 2 phenotype phenotype NOUN ct-9360 65 3 often often ADV ct-9360 65 4 influences influence VERB ct-9360 65 5 receptor receptor NOUN ct-9360 65 6 expression expression NOUN ct-9360 65 7 . . PUNCT ct-9360 66 1 for for ADP ct-9360 66 2 example example NOUN ct-9360 66 3 , , PUNCT ct-9360 66 4 most most ADJ ct-9360 66 5 human human PROPN ct-9360 66 6 b b PROPN ct-9360 66 7 cell cell NOUN ct-9360 66 8 lymphomas lymphoma NOUN ct-9360 66 9 depended depend VERB ct-9360 66 10 on on ADP ct-9360 66 11 the the DET ct-9360 66 12 expression expression NOUN ct-9360 66 13 of of ADP ct-9360 66 14 a a DET ct-9360 66 15 b b NOUN ct-9360 66 16 cell cell NOUN ct-9360 66 17 receptor receptor NOUN ct-9360 66 18 for for ADP ct-9360 66 19 continued continue VERB ct-9360 66 20 growth.29 growth.29 NOUN ct-9360 66 21 in in ADP ct-9360 66 22 dogs dog NOUN ct-9360 66 23 , , PUNCT ct-9360 66 24 the the DET ct-9360 66 25 retinoid retinoid NOUN ct-9360 66 26 receptor receptor NOUN ct-9360 66 27 is be AUX ct-9360 66 28 expressed express VERB ct-9360 66 29 higher high ADJ ct-9360 66 30 in in ADP ct-9360 66 31 t t NOUN ct-9360 66 32 cell cell NOUN ct-9360 66 33 lymphomas lymphoma NOUN ct-9360 66 34 compared compare VERB ct-9360 66 35 to to ADP ct-9360 66 36 b b PROPN ct-9360 66 37 cell cell NOUN ct-9360 66 38 lymphomas.30 lymphomas.30 NOUN ct-9360 66 39 therefore therefore ADV ct-9360 66 40 , , PUNCT ct-9360 66 41 1 1 NUM ct-9360 66 42 objective objective NOUN ct-9360 66 43 of of ADP ct-9360 66 44 the the DET ct-9360 66 45 current current ADJ ct-9360 66 46 study study NOUN ct-9360 66 47 was be AUX ct-9360 66 48 to to PART ct-9360 66 49 determine determine VERB ct-9360 66 50 if if SCONJ ct-9360 66 51 lhr lhr ADJ ct-9360 66 52 expression expression NOUN ct-9360 66 53 changed change VERB ct-9360 66 54 with with ADP ct-9360 66 55 lymphoma lymphoma NOUN ct-9360 66 56 phenotype phenotype NOUN ct-9360 66 57 . . PUNCT ct-9360 67 1 although although SCONJ ct-9360 67 2 more more ADJ ct-9360 67 3 b b NOUN ct-9360 67 4 cell cell NOUN ct-9360 67 5 lymphomas lymphoma NOUN ct-9360 67 6 were be AUX ct-9360 67 7 present present ADJ ct-9360 67 8 in in ADP ct-9360 67 9 the the DET ct-9360 67 10 data data NOUN ct-9360 67 11 set set NOUN ct-9360 67 12 ( ( PUNCT ct-9360 67 13 n n NOUN ct-9360 67 14 = = NUM ct-9360 67 15 20 20 NUM ct-9360 67 16 ) ) PUNCT ct-9360 67 17 than than ADP ct-9360 67 18 t t NOUN ct-9360 67 19 cell cell NOUN ct-9360 67 20 lymphomas lymphoma NOUN ct-9360 67 21 ( ( PUNCT ct-9360 67 22 n n NOUN ct-9360 67 23 = = SYM ct-9360 67 24 6 6 NUM ct-9360 67 25 ) ) PUNCT ct-9360 67 26 , , PUNCT ct-9360 67 27 there there PRON ct-9360 67 28 was be VERB ct-9360 67 29 no no DET ct-9360 67 30 significant significant ADJ ct-9360 67 31 difference difference NOUN ct-9360 67 32 between between ADP ct-9360 67 33 phenotypes phenotype NOUN ct-9360 67 34 in in ADP ct-9360 67 35 the the DET ct-9360 67 36 relative relative ADJ ct-9360 67 37 percentage percentage NOUN ct-9360 67 38 of of ADP ct-9360 67 39 cells cell NOUN ct-9360 67 40 expressing express VERB ct-9360 67 41 lhr lhr NOUN ct-9360 67 42 , , PUNCT ct-9360 67 43 nor nor CCONJ ct-9360 67 44 in in ADP ct-9360 67 45 the the DET ct-9360 67 46 relative relative ADJ ct-9360 67 47 intensity intensity NOUN ct-9360 67 48 of of ADP ct-9360 67 49 lhr lhr ADJ ct-9360 67 50 staining staining NOUN ct-9360 67 51 . . PUNCT ct-9360 68 1 receptor receptor NOUN ct-9360 68 2 expression expression NOUN ct-9360 68 3 also also ADV ct-9360 68 4 can can AUX ct-9360 68 5 vary vary VERB ct-9360 68 6 with with ADP ct-9360 68 7 advancing advance VERB ct-9360 68 8 tumor tumor NOUN ct-9360 68 9 stage stage NOUN ct-9360 68 10 . . PUNCT ct-9360 69 1 for for ADP ct-9360 69 2 example example NOUN ct-9360 69 3 , , PUNCT ct-9360 69 4 estrogen estrogen NOUN ct-9360 69 5 receptor receptor NOUN ct-9360 69 6 beta beta NOUN ct-9360 69 7 was be AUX ct-9360 69 8 expressed express VERB ct-9360 69 9 higher higher ADV ct-9360 69 10 in in ADP ct-9360 69 11 human human ADJ ct-9360 69 12 b b PROPN ct-9360 69 13 cell cell NOUN ct-9360 69 14 lymphoma lymphoma NOUN ct-9360 69 15 with with ADP ct-9360 69 16 tumor tumor NOUN ct-9360 69 17 stage stage NOUN ct-9360 69 18 of of ADP ct-9360 69 19 iii iii NUM ct-9360 69 20 or or CCONJ ct-9360 69 21 iv.31 iv.31 NOUN ct-9360 69 22 alternatively alternatively ADV ct-9360 69 23 , , PUNCT ct-9360 69 24 lhr lhr ADJ ct-9360 69 25 expression expression NOUN ct-9360 69 26 in in ADP ct-9360 69 27 human human ADJ ct-9360 69 28 ovarian ovarian ADJ ct-9360 69 29 cancer cancer NOUN ct-9360 69 30 was be AUX ct-9360 69 31 higher high ADJ ct-9360 69 32 in in ADP ct-9360 69 33 stages stage NOUN ct-9360 69 34 i i PRON ct-9360 69 35 and and CCONJ ct-9360 69 36 ii ii NOUN ct-9360 69 37 compared compare VERB ct-9360 69 38 to to ADP ct-9360 69 39 stages stage NOUN ct-9360 69 40 iii iii NOUN ct-9360 69 41 and and CCONJ ct-9360 69 42 iv.32 iv.32 VERB ct-9360 69 43 in in ADP ct-9360 69 44 the the DET ct-9360 69 45 current current ADJ ct-9360 69 46 study study NOUN ct-9360 69 47 , , PUNCT ct-9360 69 48 lhr lhr ADJ ct-9360 69 49 expression expression NOUN ct-9360 69 50 varied vary VERB ct-9360 69 51 widely widely ADV ct-9360 69 52 within within ADP ct-9360 69 53 tumor tumor NOUN ct-9360 69 54 stage stage NOUN ct-9360 69 55 , , PUNCT ct-9360 69 56 similar similar ADJ ct-9360 69 57 to to ADP ct-9360 69 58 reported report VERB ct-9360 69 59 expression expression NOUN ct-9360 69 60 of of ADP ct-9360 69 61 steroid steroid NOUN ct-9360 69 62 hormone hormone NOUN ct-9360 69 63 receptors receptor NOUN ct-9360 69 64 in in ADP ct-9360 69 65 canine canine NOUN ct-9360 69 66 and and CCONJ ct-9360 69 67 human human ADJ ct-9360 69 68 mammary mammary NOUN ct-9360 69 69 tumors.33 tumors.33 PROPN ct-9360 69 70 - - PUNCT ct-9360 69 71 35 35 NUM ct-9360 69 72 lack lack NOUN ct-9360 69 73 of of ADP ct-9360 69 74 association association NOUN ct-9360 69 75 between between ADP ct-9360 69 76 receptor receptor NOUN ct-9360 69 77 expression expression NOUN ct-9360 69 78 and and CCONJ ct-9360 69 79 tumor tumor NOUN ct-9360 69 80 stage stage NOUN ct-9360 69 81 could could AUX ct-9360 69 82 result result VERB ct-9360 69 83 from from ADP ct-9360 69 84 the the DET ct-9360 69 85 nonstatic nonstatic ADJ ct-9360 69 86 expression expression NOUN ct-9360 69 87 of of ADP ct-9360 69 88 lhr lhr NOUN ct-9360 69 89 in in ADP ct-9360 69 90 tumors tumor NOUN ct-9360 69 91 , , PUNCT ct-9360 69 92 as as SCONJ ct-9360 69 93 reported report VERB ct-9360 69 94 with with ADP ct-9360 69 95 lipoprotein lipoprotein ADJ ct-9360 69 96 receptors receptor NOUN ct-9360 69 97 in in ADP ct-9360 69 98 canine canine NOUN ct-9360 69 99 lymphoma.36 lymphoma.36 NOUN ct-9360 69 100 activation activation NOUN ct-9360 69 101 of of ADP ct-9360 69 102 lhr lhr NOUN ct-9360 69 103 in in ADP ct-9360 69 104 luteal,37,38 luteal,37,38 PROPN ct-9360 69 105 trophoblast,39 trophoblast,39 NOUN ct-9360 69 106 or or CCONJ ct-9360 69 107 canine canine NOUN ct-9360 69 108 t t PROPN ct-9360 69 109 cell cell NOUN ct-9360 69 110 lymphoma lymphoma NOUN ct-9360 69 111 cells40 cells40 NOUN ct-9360 69 112 resulted result VERB ct-9360 69 113 in in ADP ct-9360 69 114 dosedependent dosedependent NOUN ct-9360 69 115 cell cell NOUN ct-9360 69 116 proliferation proliferation NOUN ct-9360 69 117 . . PUNCT ct-9360 70 1 because because SCONJ ct-9360 70 2 circulating circulate VERB ct-9360 70 3 lh lh PROPN ct-9360 70 4 concentrations concentration NOUN ct-9360 70 5 were be AUX ct-9360 70 6 significantly significantly ADV ct-9360 70 7 higher high ADJ ct-9360 70 8 in in ADP ct-9360 70 9 spayed spay VERB ct-9360 70 10 and and CCONJ ct-9360 70 11 neutered neuter VERB ct-9360 70 12 dogs,41 dogs,41 NOUN ct-9360 70 13 it it PRON ct-9360 70 14 is be AUX ct-9360 70 15 possible possible ADJ ct-9360 70 16 that that SCONJ ct-9360 70 17 lhr lhr ADJ ct-9360 70 18 activation activation NOUN ct-9360 70 19 has have VERB ct-9360 70 20 a a DET ct-9360 70 21 role role NOUN ct-9360 70 22 in in ADP ct-9360 70 23 the the DET ct-9360 70 24 etiopathogenesis etiopathogenesis NOUN ct-9360 70 25 of of ADP ct-9360 70 26 canine canine NOUN ct-9360 70 27 lymphoma lymphoma NOUN ct-9360 70 28 . . PUNCT ct-9360 71 1 additional additional ADJ ct-9360 71 2 research research NOUN ct-9360 71 3 is be AUX ct-9360 71 4 needed need VERB ct-9360 71 5 to to PART ct-9360 71 6 determine determine VERB ct-9360 71 7 if if SCONJ ct-9360 71 8 reducing reduce VERB ct-9360 71 9 lh lh PROPN ct-9360 71 10 concentrations concentration NOUN ct-9360 71 11 in in ADP ct-9360 71 12 spayed spay VERB ct-9360 71 13 and and CCONJ ct-9360 71 14 neutered neuter VERB ct-9360 71 15 dogs dog NOUN ct-9360 71 16 with with ADP ct-9360 71 17 a a DET ct-9360 71 18 gonadotropin gonadotropin NOUN ct-9360 71 19 - - PUNCT ct-9360 71 20 releasing release VERB ct-9360 71 21 hormone hormone NOUN ct-9360 71 22 agonist agonist NOUN ct-9360 71 23 prolongs prolong VERB ct-9360 71 24 survival survival NOUN ct-9360 71 25 time time NOUN ct-9360 71 26 in in ADP ct-9360 71 27 dogs dog NOUN ct-9360 71 28 with with ADP ct-9360 71 29 canine canine NOUN ct-9360 71 30 lymphoma lymphoma NOUN ct-9360 71 31 . . PUNCT ct-9360 72 1 acknowledgement acknowledgement PROPN ct-9360 72 2 pfizer pfizer PROPN ct-9360 72 3 canine canine VERB ct-9360 72 4 comparative comparative ADJ ct-9360 72 5 oncology oncology NOUN ct-9360 72 6 and and CCONJ ct-9360 72 7 genomics genomics NOUN ct-9360 72 8 consortium consortium NOUN ct-9360 72 9 biospecimen biospeciman NOUN ct-9360 72 10 repository repository VERB ct-9360 72 11 for for ADP ct-9360 72 12 access access NOUN ct-9360 72 13 to to PART ct-9360 72 14 study study VERB ct-9360 72 15 specimens specimen NOUN ct-9360 72 16 and and CCONJ ct-9360 72 17 christina christina PROPN ct-9360 72 18 mazcko mazcko PROPN ct-9360 72 19 for for ADP ct-9360 72 20 assistance assistance NOUN ct-9360 72 21 with with ADP ct-9360 72 22 patient patient ADJ ct-9360 72 23 data datum NOUN ct-9360 72 24 . . PUNCT ct-9360 73 1 conflict conflict NOUN ct-9360 73 2 of of ADP ct-9360 73 3 interest interest NOUN ct-9360 73 4 authors author NOUN ct-9360 73 5 declare declare VERB ct-9360 73 6 no no DET ct-9360 73 7 potential potential ADJ ct-9360 73 8 conflicts conflict NOUN ct-9360 73 9 of of ADP ct-9360 73 10 interest interest NOUN ct-9360 73 11 with with ADP ct-9360 73 12 respect respect NOUN ct-9360 73 13 to to ADP ct-9360 73 14 the the DET ct-9360 73 15 research research NOUN ct-9360 73 16 , , PUNCT ct-9360 73 17 authorship authorship NOUN ct-9360 73 18 , , PUNCT ct-9360 73 19 and/or and/or CCONJ ct-9360 73 20 publication publication NOUN ct-9360 73 21 of of ADP ct-9360 73 22 this this DET ct-9360 73 23 article article NOUN ct-9360 73 24 . . PUNCT ct-9360 74 1 funding fund VERB ct-9360 74 2 oregon oregon PROPN ct-9360 74 3 state state PROPN ct-9360 74 4 university university PROPN ct-9360 74 5 small small ADJ ct-9360 74 6 grants grant NOUN ct-9360 74 7 incentive incentive NOUN ct-9360 74 8 program program NOUN ct-9360 74 9 and and CCONJ ct-9360 74 10 undergraduate undergraduate NOUN ct-9360 74 11 research research NOUN ct-9360 74 12 scholarship scholarship NOUN ct-9360 74 13 and and CCONJ ct-9360 74 14 arts art NOUN ct-9360 74 15 program program NOUN ct-9360 74 16 . . PUNCT ct-9360 75 1 clinical clinical ADJ ct-9360 75 2 theriogenology theriogenology NOUN ct-9360 75 3 • • NOUN ct-9360 75 4 volume volume NOUN ct-9360 75 5 13 13 NUM ct-9360 75 6 number number NOUN ct-9360 75 7 1 1 NUM ct-9360 75 8 • • NUM ct-9360 75 9 march march NOUN ct-9360 75 10 2021 2021 NUM ct-9360 75 11 42 42 NUM ct-9360 75 12     SPACE ct-9360 75 13 references reference NOUN ct-9360 75 14 1 1 NUM ct-9360 75 15 . . PUNCT ct-9360 75 16 macewen macewen PROPN ct-9360 75 17 eg eg PROPN ct-9360 75 18 , , PUNCT ct-9360 75 19 hayes hayes PROPN ct-9360 75 20 aa aa PROPN ct-9360 75 21 , , PUNCT ct-9360 75 22 matus matus PROPN ct-9360 75 23 re re PROPN ct-9360 75 24 , , PUNCT ct-9360 75 25 et et PROPN ct-9360 75 26 al al PROPN ct-9360 75 27 : : PUNCT ct-9360 75 28 evaluation evaluation NOUN ct-9360 75 29 of of ADP ct-9360 75 30 some some DET ct-9360 75 31 prognostic prognostic ADJ ct-9360 75 32 factors factor NOUN ct-9360 75 33 for for ADP ct-9360 75 34 advanced advanced ADJ ct-9360 75 35 multicentric multicentric ADJ ct-9360 75 36 lymphosarcoma lymphosarcoma NOUN ct-9360 75 37 in in ADP ct-9360 75 38 the the DET ct-9360 75 39 dog dog NOUN ct-9360 75 40 : : PUNCT ct-9360 75 41 147 147 NUM ct-9360 75 42 cases case NOUN ct-9360 75 43 ( ( PUNCT ct-9360 75 44 1978 1978 NUM ct-9360 75 45 - - SYM ct-9360 75 46 1981 1981 NUM ct-9360 75 47 ) ) PUNCT ct-9360 75 48 . . PUNCT ct-9360 76 1 j j PROPN ct-9360 76 2 am be AUX ct-9360 76 3 vet vet NOUN ct-9360 76 4 med med ADJ ct-9360 76 5 assoc assoc NOUN ct-9360 76 6 1987;190:564 1987;190:564 NUM ct-9360 76 7 - - SYM ct-9360 76 8 568 568 NUM ct-9360 76 9 . . NOUN ct-9360 77 1 2 2 NUM ct-9360 77 2 . . X ct-9360 77 3 vail vail PROPN ct-9360 77 4 dm dm PROPN ct-9360 77 5 , , PUNCT ct-9360 77 6 macewen macewen PROPN ct-9360 77 7 , , PUNCT ct-9360 77 8 eg eg NOUN ct-9360 77 9 , , PUNCT ct-9360 77 10 young young ADJ ct-9360 77 11 km km NOUN ct-9360 77 12 : : PUNCT ct-9360 77 13 canine canine VERB ct-9360 77 14 lymphoma lymphoma NOUN ct-9360 77 15 and and CCONJ ct-9360 77 16 lymphoid lymphoid ADJ ct-9360 77 17 leukemia leukemia NOUN ct-9360 77 18 . . PUNCT ct-9360 78 1 in in ADP ct-9360 78 2 : : PUNCT ct-9360 78 3 withrow withrow PROPN ct-9360 78 4 sj sj PROPN ct-9360 78 5 , , PUNCT ct-9360 78 6 macewen macewen PROPN ct-9360 78 7 eg eg NOUN ct-9360 78 8 : : PUNCT ct-9360 78 9 editors editor NOUN ct-9360 78 10 . . PUNCT ct-9360 79 1 small small ADJ ct-9360 79 2 animal animal NOUN ct-9360 79 3 clinical clinical ADJ ct-9360 79 4 oncology oncology NOUN ct-9360 79 5 , , PUNCT ct-9360 79 6 3nd 3nd ADJ ct-9360 79 7 edition edition NOUN ct-9360 79 8 , , PUNCT ct-9360 79 9 philadelphia philadelphia PROPN ct-9360 79 10 ; ; PUNCT ct-9360 79 11 wb wb PROPN ct-9360 79 12 saunders saunder NOUN ct-9360 79 13 : : PUNCT ct-9360 79 14 2001 2001 NUM ct-9360 79 15 . . PUNCT ct-9360 80 1 p. p. NOUN ct-9360 80 2 558 558 NUM ct-9360 80 3 - - SYM ct-9360 80 4 590 590 NUM ct-9360 80 5 . . PUNCT ct-9360 81 1 3 3 X ct-9360 81 2 . . X ct-9360 81 3 caniatti caniatti PROPN ct-9360 81 4 m m PROPN ct-9360 81 5 , , PUNCT ct-9360 81 6 roccabianca roccabianca VERB ct-9360 81 7 p p X ct-9360 81 8 , , PUNCT ct-9360 81 9 scanziani scanziani PROPN ct-9360 81 10 e e NOUN ct-9360 81 11 , , PUNCT ct-9360 81 12 et et PROPN ct-9360 81 13 al al PROPN ct-9360 81 14 : : PUNCT ct-9360 81 15 canine canine NOUN ct-9360 81 16 lymphoma lymphoma NOUN ct-9360 81 17 : : PUNCT ct-9360 81 18 immunocytochemical immunocytochemical ADJ ct-9360 81 19 analysis analysis NOUN ct-9360 81 20 of of ADP ct-9360 81 21 fine fine ADJ ct-9360 81 22 - - PUNCT ct-9360 81 23 needle needle NOUN ct-9360 81 24 aspiration aspiration NOUN ct-9360 81 25 biopsy biopsy NOUN ct-9360 81 26 . . PUNCT ct-9360 82 1 vet vet NOUN ct-9360 82 2 pathol pathol NOUN ct-9360 82 3 1996;33:204 1996;33:204 X ct-9360 82 4 - - PUNCT ct-9360 82 5 212 212 NUM ct-9360 82 6 . . PUNCT ct-9360 83 1 4 4 X ct-9360 83 2 . . X ct-9360 83 3 burke burke PROPN ct-9360 83 4 , , PUNCT ct-9360 83 5 a a DET ct-9360 83 6 : : PUNCT ct-9360 83 7 lymphoma lymphoma NOUN ct-9360 83 8 in in ADP ct-9360 83 9 dogs dog NOUN ct-9360 83 10 : : PUNCT ct-9360 83 11 symptoms symptom NOUN ct-9360 83 12 , , PUNCT ct-9360 83 13 diagnosis diagnosis NOUN ct-9360 83 14 , , PUNCT ct-9360 83 15 and and CCONJ ct-9360 83 16 treatment treatment NOUN ct-9360 83 17 . . PUNCT ct-9360 84 1 american american ADJ ct-9360 84 2 kennel kennel PROPN ct-9360 84 3 club club PROPN ct-9360 84 4 . . PUNCT ct-9360 85 1 november november PROPN ct-9360 85 2 3 3 NUM ct-9360 85 3 , , PUNCT ct-9360 85 4 2016 2016 NUM ct-9360 85 5 . . PUNCT ct-9360 86 1 accessed access VERB ct-9360 86 2 april april PROPN ct-9360 86 3 22 22 NUM ct-9360 86 4 , , PUNCT ct-9360 86 5 2018 2018 NUM ct-9360 86 6 . . PUNCT ct-9360 87 1 available available ADJ ct-9360 87 2 from from ADP ct-9360 87 3 : : PUNCT ct-9360 87 4 https://www.akc.org/expert-advice/health/common-conditions/lymphoma-indogs-symptoms-diagnosis-and-treatment/. https://www.akc.org/expert-advice/health/common-conditions/lymphoma-indogs-symptoms-diagnosis-and-treatment/. PROPN ct-9360 87 5 5 5 NUM ct-9360 87 6 . . PUNCT ct-9360 87 7 marconato marconato PROPN ct-9360 87 8 l l NOUN ct-9360 87 9 , , PUNCT ct-9360 87 10 gelain gelain VERB ct-9360 87 11 me i PRON ct-9360 87 12 , , PUNCT ct-9360 87 13 comazzi comazzi VERB ct-9360 87 14 s s PART ct-9360 87 15 : : PUNCT ct-9360 87 16 the the DET ct-9360 87 17 dog dog NOUN ct-9360 87 18 as as ADP ct-9360 87 19 a a DET ct-9360 87 20 possible possible ADJ ct-9360 87 21 animal animal NOUN ct-9360 87 22 model model NOUN ct-9360 87 23 for for ADP ct-9360 87 24 human human ADJ ct-9360 87 25 non non ADJ ct-9360 87 26 - - ADJ ct-9360 87 27 hodgkin hodgkin ADJ ct-9360 87 28 lymphoma lymphoma NOUN ct-9360 87 29 : : PUNCT ct-9360 87 30 a a DET ct-9360 87 31 review review NOUN ct-9360 87 32 . . PUNCT ct-9360 88 1 hematol hematol ADJ ct-9360 88 2 oncol oncol ADJ ct-9360 88 3 2013;31:1 2013;31:1 NUM ct-9360 88 4 - - SYM ct-9360 88 5 9 9 NUM ct-9360 88 6 . . NOUN ct-9360 88 7 6 6 NUM ct-9360 88 8 . . X ct-9360 89 1 fan fan PROPN ct-9360 89 2 tm tm NOUN ct-9360 89 3 : : PUNCT ct-9360 89 4 overview overview NOUN ct-9360 89 5 of of ADP ct-9360 89 6 canine canine NOUN ct-9360 89 7 lymphoma lymphoma NOUN ct-9360 89 8 circulatory circulatory ADJ ct-9360 89 9 system system NOUN ct-9360 89 10 . . PUNCT ct-9360 90 1 mvm mvm PROPN ct-9360 90 2 . . PROPN ct-9360 90 3 2018 2018 NUM ct-9360 90 4 . . PUNCT ct-9360 91 1 accessed access VERB ct-9360 91 2 april april PROPN ct-9360 91 3 21 21 NUM ct-9360 91 4 , , PUNCT ct-9360 91 5 2018 2018 NUM ct-9360 91 6 . . PUNCT ct-9360 92 1 available available ADJ ct-9360 92 2 from from ADP ct-9360 92 3 : : PUNCT ct-9360 92 4 https://www.merckvetmanual.com/circulatory-system/canine-lymphoma/overview-of-canine-lymphoma https://www.merckvetmanual.com/circulatory-system/canine-lymphoma/overview-of-canine-lymphoma PROPN ct-9360 92 5 . . NOUN ct-9360 92 6 7 7 NUM ct-9360 92 7 . . X ct-9360 92 8 greenlee greenlee PROPN ct-9360 92 9 pg pg PROPN ct-9360 92 10 , , PUNCT ct-9360 92 11 filippa filippa PROPN ct-9360 92 12 da da PROPN ct-9360 92 13 , , PUNCT ct-9360 92 14 quimby quimby PROPN ct-9360 92 15 fw fw PROPN ct-9360 92 16 , , PUNCT ct-9360 92 17 et et PROPN ct-9360 92 18 al al PROPN ct-9360 92 19 : : PUNCT ct-9360 92 20 lymphomas lymphoma NOUN ct-9360 92 21 in in ADP ct-9360 92 22 dogs dog NOUN ct-9360 92 23 . . PUNCT ct-9360 93 1 a a DET ct-9360 93 2 morphologic morphologic ADJ ct-9360 93 3 , , PUNCT ct-9360 93 4 immunologic immunologic ADJ ct-9360 93 5 , , PUNCT ct-9360 93 6 and and CCONJ ct-9360 93 7 clinical clinical ADJ ct-9360 93 8 study study NOUN ct-9360 93 9 . . PUNCT ct-9360 94 1 cancer cancer NOUN ct-9360 94 2 1990;66:480 1990;66:480 PROPN ct-9360 94 3 - - SYM ct-9360 94 4 490 490 NUM ct-9360 94 5 . . NOUN ct-9360 94 6 8 8 NUM ct-9360 94 7 . . X ct-9360 94 8 teske teske PROPN ct-9360 94 9 e. e. PROPN ct-9360 94 10 canine canine PROPN ct-9360 94 11 malignant malignant ADJ ct-9360 94 12 lymphoma lymphoma NOUN ct-9360 94 13 : : PUNCT ct-9360 94 14 a a DET ct-9360 94 15 review review NOUN ct-9360 94 16 and and CCONJ ct-9360 94 17 comparison comparison NOUN ct-9360 94 18 with with ADP ct-9360 94 19 human human ADJ ct-9360 94 20 non‐hodgkins non‐hodgkin NOUN ct-9360 94 21 lymphoma lymphoma NOUN ct-9360 94 22 . . PUNCT ct-9360 95 1 vet vet NOUN ct-9360 95 2 q q ADJ ct-9360 96 1 1994;16:209 1994;16:209 NUM ct-9360 96 2 - - SYM ct-9360 96 3 219 219 NUM ct-9360 96 4 . . PUNCT ct-9360 97 1 9 9 NUM ct-9360 97 2 . . X ct-9360 97 3 valli valli PROPN ct-9360 97 4 ve ve PROPN ct-9360 97 5 , , PUNCT ct-9360 97 6 kass kass PROPN ct-9360 97 7 ph ph PROPN ct-9360 97 8 , , PUNCT ct-9360 97 9 san san PROPN ct-9360 97 10 myint myint PROPN ct-9360 97 11 m m PROPN ct-9360 97 12 , , PUNCT ct-9360 97 13 et et PROPN ct-9360 97 14 al al PROPN ct-9360 97 15 : : PUNCT ct-9360 97 16 canine canine NOUN ct-9360 97 17 lymphomas lymphoma NOUN ct-9360 97 18 . . PUNCT ct-9360 98 1 vet vet NOUN ct-9360 98 2 path path NOUN ct-9360 98 3 2013 2013 NUM ct-9360 98 4 ; ; PUNCT ct-9360 98 5 50;738 50;738 NUM ct-9360 98 6 - - SYM ct-9360 98 7 748 748 NUM ct-9360 98 8 . . PUNCT ct-9360 98 9 10 10 NUM ct-9360 98 10 . . PUNCT ct-9360 99 1 villamil villamil PROPN ct-9360 99 2 ja ja PROPN ct-9360 99 3 , , PUNCT ct-9360 99 4 henry henry PROPN ct-9360 99 5 cj cj PROPN ct-9360 99 6 , , PUNCT ct-9360 99 7 hahn hahn PROPN ct-9360 99 8 aw aw INTJ ct-9360 99 9 , , PUNCT ct-9360 99 10 et et PROPN ct-9360 99 11 al al PROPN ct-9360 99 12 : : PUNCT ct-9360 99 13 hormonal hormonal ADJ ct-9360 99 14 and and CCONJ ct-9360 99 15 sex sex NOUN ct-9360 99 16 impact impact NOUN ct-9360 99 17 on on ADP ct-9360 99 18 the the DET ct-9360 99 19 epidemiology epidemiology NOUN ct-9360 99 20 of of ADP ct-9360 99 21 canine canine NOUN ct-9360 99 22 lymphoma lymphoma NOUN ct-9360 99 23 . . PUNCT ct-9360 100 1 j j PROPN ct-9360 100 2 cancer cancer PROPN ct-9360 100 3 epidemiol epidemiol PROPN ct-9360 100 4 2009;2009:591753 2009;2009:591753 NUM ct-9360 100 5 . . PUNCT ct-9360 101 1 11 11 NUM ct-9360 101 2 . . PUNCT ct-9360 102 1 comazzi comazzi PROPN ct-9360 102 2 s s PROPN ct-9360 102 3 , , PUNCT ct-9360 102 4 marelli marelli PROPN ct-9360 102 5 s s PROPN ct-9360 102 6 , , PUNCT ct-9360 102 7 cozzi cozzi NOUN ct-9360 102 8 m m PROPN ct-9360 102 9 , , PUNCT ct-9360 102 10 et et PROPN ct-9360 102 11 al al PROPN ct-9360 102 12 : : PUNCT ct-9360 102 13 breed breed NOUN ct-9360 102 14 - - PUNCT ct-9360 102 15 associated associate VERB ct-9360 102 16 risks risk NOUN ct-9360 102 17 for for ADP ct-9360 102 18 developing develop VERB ct-9360 102 19 canine canine NOUN ct-9360 102 20 lymphoma lymphoma NOUN ct-9360 102 21 differ differ VERB ct-9360 102 22 among among ADP ct-9360 102 23 countries country NOUN ct-9360 102 24 : : PUNCT ct-9360 102 25 an an DET ct-9360 102 26 european european ADJ ct-9360 102 27 canine canine PROPN ct-9360 102 28 lymphoma lymphoma NOUN ct-9360 102 29 network network NOUN ct-9360 102 30 study study NOUN ct-9360 102 31 . . PUNCT ct-9360 103 1 bmc bmc PROPN ct-9360 103 2 vet vet NOUN ct-9360 103 3 res re NOUN ct-9360 103 4 2018;14:232 2018;14:232 PROPN ct-9360 103 5 . . PROPN ct-9360 103 6 12 12 NUM ct-9360 103 7 . . PUNCT ct-9360 104 1 dobson dobson PROPN ct-9360 104 2 , , PUNCT ct-9360 104 3 jm jm PROPN ct-9360 104 4 : : PUNCT ct-9360 104 5 breed breed NOUN ct-9360 104 6 - - PUNCT ct-9360 104 7 predispositions predisposition NOUN ct-9360 104 8 to to ADP ct-9360 104 9 cancer cancer NOUN ct-9360 104 10 in in ADP ct-9360 104 11 pedigree pedigree ADJ ct-9360 104 12 dogs dog NOUN ct-9360 104 13 . . PUNCT ct-9360 105 1 isrn isrn NOUN ct-9360 105 2 vet vet VERB ct-9360 105 3 sci sci PROPN ct-9360 105 4 2013;2013:941275 2013;2013:941275 NUM ct-9360 105 5 . . PROPN ct-9360 105 6 13 13 NUM ct-9360 105 7 . . PUNCT ct-9360 106 1 hart hart PROPN ct-9360 106 2 bl bl PROPN ct-9360 106 3 , , PUNCT ct-9360 106 4 hart hart PROPN ct-9360 106 5 la la PROPN ct-9360 106 6 , , PUNCT ct-9360 106 7 thigpen thigpen VERB ct-9360 106 8 ap ap PROPN ct-9360 106 9 , , PUNCT ct-9360 106 10 et et PROPN ct-9360 106 11 al al PROPN ct-9360 106 12 : : PUNCT ct-9360 106 13 assisting assist VERB ct-9360 106 14 decision decision NOUN ct-9360 106 15 - - PUNCT ct-9360 106 16 making making NOUN ct-9360 106 17 on on ADP ct-9360 106 18 age age NOUN ct-9360 106 19 of of ADP ct-9360 106 20 neutering neuter VERB ct-9360 106 21 for for ADP ct-9360 106 22 mixed mixed ADJ ct-9360 106 23 breed breed NOUN ct-9360 106 24 dogs dog NOUN ct-9360 106 25 of of ADP ct-9360 106 26 five five NUM ct-9360 106 27 weight weight NOUN ct-9360 106 28 categories category NOUN ct-9360 106 29 : : PUNCT ct-9360 106 30 associated associate VERB ct-9360 106 31 joint joint ADJ ct-9360 106 32 disorders disorder NOUN ct-9360 106 33 and and CCONJ ct-9360 106 34 cancers cancer NOUN ct-9360 106 35 . . PUNCT ct-9360 107 1 front front ADJ ct-9360 107 2 vet vet NOUN ct-9360 107 3 sci sci PROPN ct-9360 107 4 2020;7:472 2020;7:472 NOUN ct-9360 107 5 . . PUNCT ct-9360 108 1 14 14 NUM ct-9360 108 2 . . PUNCT ct-9360 109 1 garrett garrett PROPN ct-9360 109 2 ld ld PROPN ct-9360 109 3 , , PUNCT ct-9360 109 4 thamm thamm PROPN ct-9360 109 5 dh dh PROPN ct-9360 109 6 , , PUNCT ct-9360 109 7 chun chun PROPN ct-9360 109 8 r r PROPN ct-9360 109 9 , , PUNCT ct-9360 109 10 et et PROPN ct-9360 109 11 al al PROPN ct-9360 109 12 : : PUNCT ct-9360 109 13 evaluation evaluation NOUN ct-9360 109 14 of of ADP ct-9360 109 15 a a DET ct-9360 109 16 6 6 NUM ct-9360 109 17 - - PUNCT ct-9360 109 18 month month NOUN ct-9360 109 19 chemotherapy chemotherapy NOUN ct-9360 109 20 protocol protocol NOUN ct-9360 109 21 with with ADP ct-9360 109 22 no no DET ct-9360 109 23 maintenance maintenance NOUN ct-9360 109 24 therapy therapy NOUN ct-9360 109 25 for for ADP ct-9360 109 26 dogs dog NOUN ct-9360 109 27 with with ADP ct-9360 109 28 lymphoma lymphoma NOUN ct-9360 109 29 . . PUNCT ct-9360 110 1 j j PROPN ct-9360 110 2 vet vet NOUN ct-9360 110 3 intern intern NOUN ct-9360 110 4 med me VERB ct-9360 110 5 2002;16:704 2002;16:704 PROPN ct-9360 110 6 - - PUNCT ct-9360 110 7 709 709 NUM ct-9360 110 8 . . PUNCT ct-9360 110 9 15 15 NUM ct-9360 110 10 . . X ct-9360 111 1 valerius valerius PROPN ct-9360 111 2 kd kd PROPN ct-9360 111 3 , , PUNCT ct-9360 111 4 ogilvie ogilvie PROPN ct-9360 111 5 gk gk PROPN ct-9360 111 6 , , PUNCT ct-9360 111 7 mallinckrodt mallinckrodt PROPN ct-9360 111 8 ch ch PROPN ct-9360 111 9 , , PUNCT ct-9360 111 10 et et PROPN ct-9360 111 11 al al PROPN ct-9360 111 12 : : PUNCT ct-9360 111 13 doxorubicin doxorubicin PROPN ct-9360 111 14 alone alone ADV ct-9360 111 15 or or CCONJ ct-9360 111 16 in in ADP ct-9360 111 17 combination combination NOUN ct-9360 111 18 with with ADP ct-9360 111 19 asparaginase asparaginase NOUN ct-9360 111 20 , , PUNCT ct-9360 111 21 followed follow VERB ct-9360 111 22 by by ADP ct-9360 111 23 cyclophosphamide cyclophosphamide NOUN ct-9360 111 24 , , PUNCT ct-9360 111 25 vincristine vincristine NOUN ct-9360 111 26 , , PUNCT ct-9360 111 27 and and CCONJ ct-9360 111 28 prednisone prednisone NOUN ct-9360 111 29 for for ADP ct-9360 111 30 treatment treatment NOUN ct-9360 111 31 of of ADP ct-9360 111 32 multicentric multicentric ADJ ct-9360 111 33 lymphoma lymphoma NOUN ct-9360 111 34 in in ADP ct-9360 111 35 dogs dog NOUN ct-9360 111 36 : : PUNCT ct-9360 111 37 121 121 NUM ct-9360 111 38 cases case NOUN ct-9360 111 39 ( ( PUNCT ct-9360 111 40 1987 1987 NUM ct-9360 111 41 - - SYM ct-9360 111 42 1995 1995 NUM ct-9360 111 43 ) ) PUNCT ct-9360 111 44 . . PUNCT ct-9360 112 1 j j PROPN ct-9360 112 2 am be AUX ct-9360 112 3 vet vet NOUN ct-9360 112 4 med med ADJ ct-9360 112 5 assoc assoc PROPN ct-9360 112 6 1997;210:512 1997;210:512 NUM ct-9360 112 7 - - SYM ct-9360 112 8 516 516 NUM ct-9360 112 9 . . NUM ct-9360 113 1 16 16 NUM ct-9360 113 2 . . PUNCT ct-9360 114 1 deravi deravi PROPN ct-9360 114 2 n n SYM ct-9360 114 3 , , PUNCT ct-9360 114 4 berke berke PROPN ct-9360 114 5 o o PROPN ct-9360 114 6 , , PUNCT ct-9360 114 7 woods woods PROPN ct-9360 114 8 jp jp NOUN ct-9360 114 9 , , PUNCT ct-9360 114 10 et et PROPN ct-9360 114 11 al al PROPN ct-9360 114 12 : : PUNCT ct-9360 114 13 specific specific ADJ ct-9360 114 14 immunotypes immunotype NOUN ct-9360 114 15 of of ADP ct-9360 114 16 canine canine PROPN ct-9360 114 17 t t PROPN ct-9360 114 18 cell cell NOUN ct-9360 114 19 lymphoma lymphoma NOUN ct-9360 114 20 are be AUX ct-9360 114 21 associated associate VERB ct-9360 114 22 with with ADP ct-9360 114 23 different different ADJ ct-9360 114 24 outcomes outcome NOUN ct-9360 114 25 . . PUNCT ct-9360 115 1 vet vet NOUN ct-9360 115 2 immunol immunol NOUN ct-9360 115 3 immunopathol immunopathol VERB ct-9360 115 4 2017;191:5 2017;191:5 NUM ct-9360 115 5 - - SYM ct-9360 115 6 13 13 NUM ct-9360 115 7 . . PUNCT ct-9360 115 8 17 17 NUM ct-9360 115 9 . . PUNCT ct-9360 116 1 romano romano VERB ct-9360 116 2 fr fr PROPN ct-9360 116 3 , , PUNCT ct-9360 116 4 heinze heinze PROPN ct-9360 116 5 cr cr PROPN ct-9360 116 6 , , PUNCT ct-9360 116 7 barber barber PROPN ct-9360 116 8 lg lg PROPN ct-9360 116 9 , , PUNCT ct-9360 116 10 et et PROPN ct-9360 116 11 al al PROPN ct-9360 116 12 : : PUNCT ct-9360 116 13 association association NOUN ct-9360 116 14 between between ADP ct-9360 116 15 body body NOUN ct-9360 116 16 condition condition NOUN ct-9360 116 17 score score NOUN ct-9360 116 18 and and CCONJ ct-9360 116 19 cancer cancer NOUN ct-9360 116 20 prognosis prognosis NOUN ct-9360 116 21 in in ADP ct-9360 116 22 dogs dog NOUN ct-9360 116 23 with with ADP ct-9360 116 24 lymphoma lymphoma NOUN ct-9360 116 25 and and CCONJ ct-9360 116 26 osteosarcoma osteosarcoma ADJ ct-9360 116 27 . . PUNCT ct-9360 117 1 j j PROPN ct-9360 117 2 vet vet NOUN ct-9360 117 3 intern intern NOUN ct-9360 117 4 med me VERB ct-9360 117 5 2016;30:1179 2016;30:1179 PROPN ct-9360 117 6 - - SYM ct-9360 117 7 1186 1186 NUM ct-9360 117 8 . . PUNCT ct-9360 118 1 18 18 NUM ct-9360 118 2 . . NUM ct-9360 119 1 afshar afshar PRON ct-9360 119 2 n n CCONJ ct-9360 119 3 , , PUNCT ct-9360 119 4 english english PROPN ct-9360 119 5 dr dr PROPN ct-9360 119 6 , , PUNCT ct-9360 119 7 thursfield thursfield VERB ct-9360 119 8 v v ADP ct-9360 119 9 , , PUNCT ct-9360 119 10 et et PROPN ct-9360 119 11 al al PROPN ct-9360 119 12 : : PUNCT ct-9360 119 13 differences difference NOUN ct-9360 119 14 in in ADP ct-9360 119 15 cancer cancer NOUN ct-9360 119 16 survival survival NOUN ct-9360 119 17 by by ADP ct-9360 119 18 sex sex NOUN ct-9360 119 19 : : PUNCT ct-9360 119 20 a a DET ct-9360 119 21 population population NOUN ct-9360 119 22 - - PUNCT ct-9360 119 23 based base VERB ct-9360 119 24 study study NOUN ct-9360 119 25 using use VERB ct-9360 119 26 cancer cancer NOUN ct-9360 119 27 registry registry NOUN ct-9360 119 28 data data PROPN ct-9360 119 29 . . PUNCT ct-9360 120 1 cancer cancer NOUN ct-9360 120 2 causes cause VERB ct-9360 120 3 control control VERB ct-9360 120 4 2018;29:1059 2018;29:1059 NUM ct-9360 120 5 - - SYM ct-9360 120 6 1069 1069 NUM ct-9360 120 7 . . PUNCT ct-9360 121 1 19 19 NUM ct-9360 121 2 . . X ct-9360 121 3 radkiewicz radkiewicz PROPN ct-9360 121 4 c c PROPN ct-9360 121 5 , , PUNCT ct-9360 121 6 johansson johansson PROPN ct-9360 121 7 alv alv PROPN ct-9360 121 8 , , PUNCT ct-9360 121 9 dickman dickman PROPN ct-9360 121 10 pw pw PROPN ct-9360 121 11 , , PUNCT ct-9360 121 12 et et PROPN ct-9360 121 13 al al PROPN ct-9360 121 14 : : PUNCT ct-9360 121 15 sex sex NOUN ct-9360 121 16 differences difference NOUN ct-9360 121 17 in in ADP ct-9360 121 18 cancer cancer NOUN ct-9360 121 19 risk risk NOUN ct-9360 121 20 and and CCONJ ct-9360 121 21 survival survival NOUN ct-9360 121 22 : : PUNCT ct-9360 121 23 a a DET ct-9360 121 24 swedish swedish ADJ ct-9360 121 25 cohort cohort NOUN ct-9360 121 26 study study NOUN ct-9360 121 27 . . PUNCT ct-9360 122 1 eur eur PROPN ct-9360 122 2 j j PROPN ct-9360 122 3 cancer cancer PROPN ct-9360 122 4 2017;84:130 2017;84:130 NUM ct-9360 122 5 - - SYM ct-9360 122 6 140 140 NUM ct-9360 122 7 . . NOUN ct-9360 122 8 20 20 NUM ct-9360 122 9 . . PUNCT ct-9360 123 1 cook cook VERB ct-9360 123 2 mb mb PROPN ct-9360 123 3 , , PUNCT ct-9360 123 4 katherine katherine PROPN ct-9360 123 5 am am PROPN ct-9360 123 6 , , PUNCT ct-9360 123 7 susan susan PROPN ct-9360 123 8 sd sd PROPN ct-9360 123 9 , , PUNCT ct-9360 123 10 et et PROPN ct-9360 123 11 al al PROPN ct-9360 123 12 : : PUNCT ct-9360 123 13 " " PUNCT ct-9360 123 14 sex sex NOUN ct-9360 123 15 disparities disparity NOUN ct-9360 123 16 in in ADP ct-9360 123 17 cancer cancer NOUN ct-9360 123 18 mortality mortality NOUN ct-9360 123 19 and and CCONJ ct-9360 123 20 survival survival NOUN ct-9360 123 21 . . PUNCT ct-9360 123 22 " " PUNCT ct-9360 124 1 cancer cancer NOUN ct-9360 124 2 epidemiol epidemiol PROPN ct-9360 124 3 biomarkers biomarker NOUN ct-9360 124 4 prev prev VERB ct-9360 124 5 2011;20:1629 2011;20:1629 NUM ct-9360 124 6 - - SYM ct-9360 124 7 1637 1637 NUM ct-9360 124 8 . . PUNCT ct-9360 125 1 21 21 NUM ct-9360 125 2 . . PUNCT ct-9360 126 1 ettinger ettinger PROPN ct-9360 126 2 am am PROPN ct-9360 126 3 , , PUNCT ct-9360 126 4 gust gust NOUN ct-9360 126 5 sk sk NOUN ct-9360 126 6 , , PUNCT ct-9360 126 7 kutzler kutzler NOUN ct-9360 126 8 ma ma PROPN ct-9360 126 9 : : PUNCT ct-9360 126 10 luteinizing luteinize VERB ct-9360 126 11 hormone hormone NOUN ct-9360 126 12 receptor receptor NOUN ct-9360 126 13 expression expression NOUN ct-9360 126 14 by by ADP ct-9360 126 15 nonneoplastic nonneoplastic ADJ ct-9360 126 16 and and CCONJ ct-9360 126 17 neoplastic neoplastic ADJ ct-9360 126 18 canine canine NOUN ct-9360 126 19 lymphocytes lymphocyte VERB ct-9360 126 20 . . PUNCT ct-9360 127 1 am be AUX ct-9360 127 2 j j PROPN ct-9360 127 3 vet vet NOUN ct-9360 127 4 res re NOUN ct-9360 127 5 2019;80:572 2019;80:572 NOUN ct-9360 127 6 - - SYM ct-9360 127 7 577 577 NUM ct-9360 127 8 . . PUNCT ct-9360 128 1 22 22 NUM ct-9360 128 2 . . PUNCT ct-9360 129 1 owen owen PROPN ct-9360 129 2 ln ln PROPN ct-9360 129 3 : : PUNCT ct-9360 129 4 tnm tnm NUM ct-9360 129 5 classification classification NOUN ct-9360 129 6 of of ADP ct-9360 129 7 tumours tumour NOUN ct-9360 129 8 in in ADP ct-9360 129 9 domestic domestic ADJ ct-9360 129 10 animals animal NOUN ct-9360 129 11 . . PUNCT ct-9360 130 1 1st 1st PROPN ct-9360 130 2 edition edition PROPN ct-9360 130 3 , , PUNCT ct-9360 130 4 geneva geneva PROPN ct-9360 130 5 ; ; PUNCT ct-9360 130 6 world world NOUN ct-9360 130 7 health health NOUN ct-9360 130 8 organization organization NOUN ct-9360 130 9 : : PUNCT ct-9360 130 10 1980 1980 NUM ct-9360 130 11 . . PUNCT ct-9360 131 1 23 23 NUM ct-9360 131 2 . . PUNCT ct-9360 132 1 hirsch hirsch PROPN ct-9360 132 2 fr fr PROPN ct-9360 132 3 , , PUNCT ct-9360 132 4 varella varella NOUN ct-9360 132 5 - - PUNCT ct-9360 132 6 garcia garcia PROPN ct-9360 132 7 m m PROPN ct-9360 132 8 , , PUNCT ct-9360 132 9 bunn bunn PROPN ct-9360 132 10 pa pa PROPN ct-9360 132 11 jr jr PROPN ct-9360 132 12 , , PUNCT ct-9360 132 13 et et PROPN ct-9360 132 14 al al PROPN ct-9360 132 15 : : PUNCT ct-9360 132 16 epidermal epidermal ADJ ct-9360 132 17 growth growth NOUN ct-9360 132 18 factor factor NOUN ct-9360 132 19 receptor receptor NOUN ct-9360 132 20 in in ADP ct-9360 132 21 non non ADJ ct-9360 132 22 - - ADJ ct-9360 132 23 small small ADJ ct-9360 132 24 - - PUNCT ct-9360 132 25 cell cell NOUN ct-9360 132 26 lung lung NOUN ct-9360 132 27 carcinomas carcinoma NOUN ct-9360 132 28 : : PUNCT ct-9360 132 29 correlation correlation NOUN ct-9360 132 30 between between ADP ct-9360 132 31 gene gene NOUN ct-9360 132 32 copy copy NOUN ct-9360 132 33 number number NOUN ct-9360 132 34 and and CCONJ ct-9360 132 35 protein protein NOUN ct-9360 132 36 expression expression NOUN ct-9360 132 37 and and CCONJ ct-9360 132 38 impact impact NOUN ct-9360 132 39 on on ADP ct-9360 132 40 prognosis prognosis NOUN ct-9360 132 41 . . PUNCT ct-9360 133 1 j j PROPN ct-9360 133 2 clin clin PROPN ct-9360 133 3 oncol oncol PROPN ct-9360 133 4 2003;21 2003;21 NOUN ct-9360 133 5 : : PUNCT ct-9360 133 6 3798 3798 NUM ct-9360 133 7 - - SYM ct-9360 133 8 3807 3807 NUM ct-9360 133 9 . . PUNCT ct-9360 134 1 24 24 NUM ct-9360 134 2 . . PUNCT ct-9360 135 1 john john PROPN ct-9360 135 2 t t PROPN ct-9360 135 3 , , PUNCT ct-9360 135 4 liu liu PROPN ct-9360 135 5 g g PROPN ct-9360 135 6 , , PUNCT ct-9360 135 7 tsao tsao PROPN ct-9360 135 8 ms ms NOUN ct-9360 135 9 : : PUNCT ct-9360 135 10 overview overview NOUN ct-9360 135 11 of of ADP ct-9360 135 12 molecular molecular ADJ ct-9360 135 13 testing testing NOUN ct-9360 135 14 in in ADP ct-9360 135 15 non non ADJ ct-9360 135 16 - - ADJ ct-9360 135 17 small small ADJ ct-9360 135 18 - - PUNCT ct-9360 135 19 cell cell NOUN ct-9360 135 20 lung lung NOUN ct-9360 135 21 cancer cancer NOUN ct-9360 135 22 : : PUNCT ct-9360 135 23 mutational mutational ADJ ct-9360 135 24 analysis analysis NOUN ct-9360 135 25 , , PUNCT ct-9360 135 26 gene gene NOUN ct-9360 135 27 copy copy NOUN ct-9360 135 28 number number NOUN ct-9360 135 29 , , PUNCT ct-9360 135 30 protein protein NOUN ct-9360 135 31 expression expression NOUN ct-9360 135 32 and and CCONJ ct-9360 135 33 other other ADJ ct-9360 135 34 biomarkers biomarker NOUN ct-9360 135 35 of of ADP ct-9360 135 36 egfr egfr NOUN ct-9360 135 37 for for ADP ct-9360 135 38 the the DET ct-9360 135 39 prediction prediction NOUN ct-9360 135 40 of of ADP ct-9360 135 41 response response NOUN ct-9360 135 42 to to ADP ct-9360 135 43 tyrosine tyrosine PROPN ct-9360 135 44 kinase kinase PROPN ct-9360 135 45 inhibitors inhibitor NOUN ct-9360 135 46 . . PUNCT ct-9360 136 1 oncogene oncogene NOUN ct-9360 136 2 2009;28 2009;28 NOUN ct-9360 136 3 : : PUNCT ct-9360 136 4 s14 s14 NOUN ct-9360 136 5 - - PUNCT ct-9360 136 6 s23 s23 NOUN ct-9360 136 7 . . PUNCT ct-9360 137 1 25 25 NUM ct-9360 137 2 . . PUNCT ct-9360 138 1 hart hart PROPN ct-9360 138 2 bl bl PROPN ct-9360 138 3 , , PUNCT ct-9360 138 4 hart hart PROPN ct-9360 138 5 la la PROPN ct-9360 138 6 , , PUNCT ct-9360 138 7 thigpen thigpen VERB ct-9360 138 8 ap ap PROPN ct-9360 138 9 , , PUNCT ct-9360 138 10 et et PROPN ct-9360 138 11 al al PROPN ct-9360 138 12 : : PUNCT ct-9360 138 13 assisting assist VERB ct-9360 138 14 decision decision NOUN ct-9360 138 15 - - PUNCT ct-9360 138 16 making making NOUN ct-9360 138 17 on on ADP ct-9360 138 18 age age NOUN ct-9360 138 19 of of ADP ct-9360 138 20 neutering neuter VERB ct-9360 138 21 for for ADP ct-9360 138 22 35 35 NUM ct-9360 138 23 breeds breed NOUN ct-9360 138 24 of of ADP ct-9360 138 25 dogs dog NOUN ct-9360 138 26 : : PUNCT ct-9360 138 27 associated associate VERB ct-9360 138 28 joint joint ADJ ct-9360 138 29 disorders disorder NOUN ct-9360 138 30 , , PUNCT ct-9360 138 31 cancers cancer NOUN ct-9360 138 32 , , PUNCT ct-9360 138 33 and and CCONJ ct-9360 138 34 urinary urinary ADJ ct-9360 138 35 incontinence incontinence NOUN ct-9360 138 36 . . PUNCT ct-9360 139 1 front front ADJ ct-9360 139 2 vet vet NOUN ct-9360 139 3 sci sci PROPN ct-9360 139 4 2020;7:388 2020;7:388 NUM ct-9360 139 5 . . PROPN ct-9360 139 6 26 26 NUM ct-9360 139 7 . . PUNCT ct-9360 139 8 reichler reichler PROPN ct-9360 140 1 i i PRON ct-9360 140 2 m m PROPN ct-9360 140 3 , , PUNCT ct-9360 140 4 welle welle PROPN ct-9360 140 5 m m PROPN ct-9360 140 6 , , PUNCT ct-9360 140 7 sattler sattler NOUN ct-9360 140 8 u u PROPN ct-9360 140 9 , , PUNCT ct-9360 140 10 et et PROPN ct-9360 140 11 al al PROPN ct-9360 140 12 : : PUNCT ct-9360 140 13 comparative comparative ADJ ct-9360 140 14 quantitative quantitative ADJ ct-9360 140 15 assessment assessment NOUN ct-9360 140 16 of of ADP ct-9360 140 17 gnrhand gnrhand NOUN ct-9360 140 18 lh lh PROPN ct-9360 140 19 - - PUNCT ct-9360 140 20 receptor receptor NOUN ct-9360 140 21 mrna mrna NOUN ct-9360 140 22 expression expression NOUN ct-9360 140 23 in in ADP ct-9360 140 24 the the DET ct-9360 140 25 urinary urinary ADJ ct-9360 140 26 tract tract NOUN ct-9360 140 27 of of ADP ct-9360 140 28 sexually sexually ADV ct-9360 140 29 intact intact ADJ ct-9360 140 30 and and CCONJ ct-9360 140 31 spayed spay VERB ct-9360 140 32 female female ADJ ct-9360 140 33 dogs dog NOUN ct-9360 140 34 . . PUNCT ct-9360 141 1 theriogenology theriogenology NOUN ct-9360 141 2 2007;67:1134 2007;67:1134 NUM ct-9360 141 3 - - NOUN ct-9360 141 4 1142 1142 NUM ct-9360 141 5 . . PUNCT ct-9360 142 1 27 27 NUM ct-9360 142 2 . . PUNCT ct-9360 143 1 keller keller PROPN ct-9360 143 2 et et PROPN ct-9360 143 3 , , PUNCT ct-9360 143 4 macewen macewen PROPN ct-9360 143 5 eg eg PROPN ct-9360 143 6 , , PUNCT ct-9360 143 7 rosenthal rosenthal PROPN ct-9360 143 8 rc rc PROPN ct-9360 143 9 , , PUNCT ct-9360 143 10 et et PROPN ct-9360 143 11 al al PROPN ct-9360 143 12 : : PUNCT ct-9360 143 13 evaluation evaluation NOUN ct-9360 143 14 of of ADP ct-9360 143 15 prognostic prognostic ADJ ct-9360 143 16 factors factor NOUN ct-9360 143 17 and and CCONJ ct-9360 143 18 sequential sequential ADJ ct-9360 143 19 combination combination NOUN ct-9360 143 20 chemotherapy chemotherapy NOUN ct-9360 143 21 with with ADP ct-9360 143 22 doxorubicin doxorubicin PROPN ct-9360 143 23 for for ADP ct-9360 143 24 canine canine NOUN ct-9360 143 25 lymphoma lymphoma NOUN ct-9360 143 26 . . PUNCT ct-9360 144 1 j j PROPN ct-9360 144 2 vet vet NOUN ct-9360 144 3 intern intern NOUN ct-9360 144 4 med me VERB ct-9360 144 5 1993;7:289 1993;7:289 NUM ct-9360 144 6 - - SYM ct-9360 144 7 295 295 NUM ct-9360 144 8 . . PUNCT ct-9360 145 1 28 28 NUM ct-9360 145 2 . . PUNCT ct-9360 146 1 zink zink PROPN ct-9360 146 2 mc mc PROPN ct-9360 146 3 , , PUNCT ct-9360 146 4 farhoody farhoody NOUN ct-9360 146 5 p p NOUN ct-9360 146 6 , , PUNCT ct-9360 146 7 elser elser NOUN ct-9360 146 8 se se PROPN ct-9360 146 9 , , PUNCT ct-9360 146 10 et et PROPN ct-9360 146 11 al al PROPN ct-9360 146 12 : : PUNCT ct-9360 146 13 evaluation evaluation NOUN ct-9360 146 14 of of ADP ct-9360 146 15 the the DET ct-9360 146 16 risk risk NOUN ct-9360 146 17 and and CCONJ ct-9360 146 18 age age NOUN ct-9360 146 19 of of ADP ct-9360 146 20 onset onset NOUN ct-9360 146 21 of of ADP ct-9360 146 22 cancer cancer NOUN ct-9360 146 23 and and CCONJ ct-9360 146 24 behavioral behavioral ADJ ct-9360 146 25 disorders disorder NOUN ct-9360 146 26 in in ADP ct-9360 146 27 gonadectomized gonadectomize VERB ct-9360 146 28 vizslas vizsla NOUN ct-9360 146 29 . . PUNCT ct-9360 147 1 j j PROPN ct-9360 147 2 am be AUX ct-9360 147 3 vet vet NOUN ct-9360 147 4 med med ADJ ct-9360 147 5 assoc assoc NOUN ct-9360 147 6 2014;244:309 2014;244:309 NUM ct-9360 147 7 - - SYM ct-9360 147 8 319 319 NUM ct-9360 147 9 . . PUNCT ct-9360 147 10 29 29 NUM ct-9360 147 11 . . PUNCT ct-9360 148 1 küppers küpper NOUN ct-9360 148 2 r r NOUN ct-9360 148 3 : : PUNCT ct-9360 148 4 mechanisms mechanism NOUN ct-9360 148 5 of of ADP ct-9360 148 6 b b NOUN ct-9360 148 7 - - PUNCT ct-9360 148 8 cell cell NOUN ct-9360 148 9 lymphoma lymphoma NOUN ct-9360 148 10 pathogenesis pathogenesis NOUN ct-9360 148 11 . . PUNCT ct-9360 149 1 nat nat PROPN ct-9360 149 2 rev rev VERB ct-9360 149 3 cancer cancer NOUN ct-9360 149 4 2005;5:251 2005;5:251 PROPN ct-9360 149 5 - - PUNCT ct-9360 149 6 262 262 NUM ct-9360 149 7 . . PUNCT ct-9360 149 8 30 30 NUM ct-9360 149 9 . . PUNCT ct-9360 150 1 de de PROPN ct-9360 150 2 mello mello PROPN ct-9360 150 3 sch sch PROPN ct-9360 150 4 , , PUNCT ct-9360 150 5 valli valli PROPN ct-9360 150 6 ve ve PROPN ct-9360 150 7 , , PUNCT ct-9360 150 8 kitchell kitchell PROPN ct-9360 150 9 be be AUX ct-9360 150 10 : : PUNCT ct-9360 150 11 detection detection NOUN ct-9360 150 12 of of ADP ct-9360 150 13 retinoid retinoid NOUN ct-9360 150 14 receptors receptor NOUN ct-9360 150 15 in in ADP ct-9360 150 16 non non ADJ ct-9360 150 17 - - ADJ ct-9360 150 18 neoplastic neoplastic ADJ ct-9360 150 19 canine canine NOUN ct-9360 150 20 lymph lymph NOUN ct-9360 150 21 nodes node NOUN ct-9360 150 22 and and CCONJ ct-9360 150 23 in in ADP ct-9360 150 24 lymphoma lymphoma NOUN ct-9360 150 25 . . PUNCT ct-9360 151 1 can can AUX ct-9360 151 2 vet vet VERB ct-9360 151 3 j j PROPN ct-9360 151 4 2014;55:1219 2014;55:1219 PROPN ct-9360 151 5 - - SYM ct-9360 151 6 24 24 NUM ct-9360 151 7 . . PUNCT ct-9360 152 1 erratum erratum PROPN ct-9360 152 2 in in ADP ct-9360 152 3 : : PUNCT ct-9360 152 4 can can AUX ct-9360 152 5 vet vet VERB ct-9360 152 6 j j PROPN ct-9360 152 7 2014;55:106 2014;55:106 X ct-9360 152 8 . . PUNCT ct-9360 153 1 clinical clinical ADJ ct-9360 153 2 theriogenology theriogenology NOUN ct-9360 153 3 • • NOUN ct-9360 153 4 volume volume NOUN ct-9360 153 5 13 13 NUM ct-9360 153 6 number number NOUN ct-9360 153 7 1 1 NUM ct-9360 153 8 • • NUM ct-9360 153 9 march march PROPN ct-9360 153 10 202143 202143 NUM ct-9360 153 11     SPACE ct-9360 153 12 31 31 NUM ct-9360 153 13 . . PUNCT ct-9360 154 1 faknuam faknuam PROPN ct-9360 154 2 s s PROPN ct-9360 154 3 , , PUNCT ct-9360 154 4 assanasen assanasen PROPN ct-9360 154 5 t t PROPN ct-9360 154 6 , , PUNCT ct-9360 154 7 ruangvejvorachai ruangvejvorachai PROPN ct-9360 154 8 p p X ct-9360 154 9 , , PUNCT ct-9360 154 10 et et PROPN ct-9360 154 11 al al PROPN ct-9360 154 12 : : PUNCT ct-9360 154 13 estrogen estrogen NOUN ct-9360 154 14 receptor receptor NOUN ct-9360 154 15 beta beta NOUN ct-9360 154 16 expression expression NOUN ct-9360 154 17 and and CCONJ ct-9360 154 18 prognosis prognosis NOUN ct-9360 154 19 of of ADP ct-9360 154 20 diffuse diffuse PROPN ct-9360 154 21 large large ADJ ct-9360 154 22 b b NOUN ct-9360 154 23 cell cell NOUN ct-9360 154 24 lymphoma lymphoma NOUN ct-9360 154 25 . . PUNCT ct-9360 155 1 hematology hematology NOUN ct-9360 155 2 2018;23:235 2018;23:235 NOUN ct-9360 155 3 - - SYM ct-9360 155 4 241 241 NUM ct-9360 155 5 . . PUNCT ct-9360 155 6 32 32 NUM ct-9360 155 7 . . PUNCT ct-9360 156 1 cui cui PROPN ct-9360 156 2 j j PROPN ct-9360 156 3 , , PUNCT ct-9360 156 4 guo guo PROPN ct-9360 156 5 y y PROPN ct-9360 156 6 , , PUNCT ct-9360 156 7 you you PRON ct-9360 156 8 z z NOUN ct-9360 156 9 : : PUNCT ct-9360 157 1 [ [ X ct-9360 157 2 lh lh ADJ ct-9360 157 3 - - PUNCT ct-9360 157 4 cg cg NOUN ct-9360 157 5 receptor receptor NOUN ct-9360 157 6 protein protein NOUN ct-9360 157 7 expression expression NOUN ct-9360 157 8 in in ADP ct-9360 157 9 epithelial epithelial ADJ ct-9360 157 10 ovarian ovarian ADJ ct-9360 157 11 cancer cancer NOUN ct-9360 157 12 ] ] PUNCT ct-9360 157 13 . . PUNCT ct-9360 158 1 zhonghua zhonghua PROPN ct-9360 158 2 fu fu PROPN ct-9360 158 3 chan chan PROPN ct-9360 158 4 ke ke PROPN ct-9360 158 5 za za PROPN ct-9360 158 6 zhi zhi PROPN ct-9360 158 7 1997;32:742 1997;32:742 ADV ct-9360 158 8 - - PUNCT ct-9360 158 9 745 745 NUM ct-9360 158 10 . . PUNCT ct-9360 159 1 33 33 NUM ct-9360 159 2 . . PUNCT ct-9360 160 1 millanta millanta PROPN ct-9360 160 2 f f PROPN ct-9360 160 3 , , PUNCT ct-9360 160 4 calandrella calandrella NOUN ct-9360 160 5 m m PROPN ct-9360 160 6 , , PUNCT ct-9360 160 7 bari bari NOUN ct-9360 160 8 g g NOUN ct-9360 160 9 , , PUNCT ct-9360 160 10 et et PROPN ct-9360 160 11 al al PROPN ct-9360 160 12 : : PUNCT ct-9360 160 13 comparison comparison NOUN ct-9360 160 14 of of ADP ct-9360 160 15 steroid steroid NOUN ct-9360 160 16 receptor receptor NOUN ct-9360 160 17 expression expression NOUN ct-9360 160 18 in in ADP ct-9360 160 19 normal normal ADJ ct-9360 160 20 , , PUNCT ct-9360 160 21 dysplastic dysplastic ADJ ct-9360 160 22 , , PUNCT ct-9360 160 23 and and CCONJ ct-9360 160 24 neoplastic neoplastic ADJ ct-9360 160 25 canine canine NOUN ct-9360 160 26 and and CCONJ ct-9360 160 27 feline feline ADJ ct-9360 160 28 mammary mammary ADJ ct-9360 160 29 tissues tissue NOUN ct-9360 160 30 . . PUNCT ct-9360 161 1 res re NOUN ct-9360 161 2 vet vet NOUN ct-9360 161 3 sci sci PROPN ct-9360 161 4 2005;79:225 2005;79:225 PROPN ct-9360 161 5 - - SYM ct-9360 161 6 232 232 NUM ct-9360 161 7 . . PUNCT ct-9360 162 1 34 34 NUM ct-9360 162 2 . . X ct-9360 162 3 bardou bardou VERB ct-9360 162 4 vj vj PROPN ct-9360 162 5 , , PUNCT ct-9360 162 6 arpino arpino PROPN ct-9360 162 7 g g PROPN ct-9360 162 8 , , PUNCT ct-9360 162 9 elledge elledge PROPN ct-9360 162 10 rm rm PROPN ct-9360 162 11 , , PUNCT ct-9360 162 12 et et PROPN ct-9360 162 13 al al PROPN ct-9360 162 14 : : PUNCT ct-9360 162 15 progesterone progesterone NOUN ct-9360 162 16 receptor receptor NOUN ct-9360 162 17 status status NOUN ct-9360 162 18 significantly significantly ADV ct-9360 162 19 improves improve VERB ct-9360 162 20 outcome outcome NOUN ct-9360 162 21 prediction prediction NOUN ct-9360 162 22 over over ADP ct-9360 162 23 estrogen estrogen NOUN ct-9360 162 24 receptor receptor NOUN ct-9360 162 25 status status NOUN ct-9360 162 26 alone alone ADJ ct-9360 162 27 for for ADP ct-9360 162 28 adjuvant adjuvant ADJ ct-9360 162 29 endocrine endocrine NOUN ct-9360 162 30 therapy therapy NOUN ct-9360 162 31 in in ADP ct-9360 162 32 two two NUM ct-9360 162 33 large large ADJ ct-9360 162 34 breast breast NOUN ct-9360 162 35 cancer cancer NOUN ct-9360 162 36 databases database NOUN ct-9360 162 37 . . PUNCT ct-9360 163 1 j j PROPN ct-9360 163 2 clin clin PROPN ct-9360 163 3 oncol oncol PROPN ct-9360 163 4 2003;21:1973 2003;21:1973 PROPN ct-9360 163 5 - - SYM ct-9360 163 6 1979 1979 NUM ct-9360 163 7 . . PUNCT ct-9360 164 1 35 35 NUM ct-9360 164 2 . . PUNCT ct-9360 165 1 pichon pichon PROPN ct-9360 165 2 mf mf PROPN ct-9360 165 3 , , PUNCT ct-9360 165 4 broet broet VERB ct-9360 165 5 p p NOUN ct-9360 165 6 , , PUNCT ct-9360 165 7 magdelenat magdelenat NOUN ct-9360 165 8 h h NOUN ct-9360 165 9 , , PUNCT ct-9360 165 10 et et PROPN ct-9360 165 11 al al PROPN ct-9360 165 12 : : PUNCT ct-9360 165 13 prognostic prognostic ADJ ct-9360 165 14 value value NOUN ct-9360 165 15 of of ADP ct-9360 165 16 steroid steroid NOUN ct-9360 165 17 receptors receptor NOUN ct-9360 165 18 after after ADP ct-9360 165 19 long long ADJ ct-9360 165 20 - - PUNCT ct-9360 165 21 term term NOUN ct-9360 165 22 follow follow NOUN ct-9360 165 23 - - PUNCT ct-9360 165 24 up up NOUN ct-9360 165 25 of of ADP ct-9360 165 26 2257 2257 NUM ct-9360 165 27 operable operable ADJ ct-9360 165 28 breast breast NOUN ct-9360 165 29 cancers cancer NOUN ct-9360 165 30 . . PUNCT ct-9360 166 1 br br PROPN ct-9360 166 2 j j PROPN ct-9360 166 3 cancer cancer PROPN ct-9360 166 4 1996;73:1545 1996;73:1545 NUM ct-9360 166 5 - - SYM ct-9360 166 6 1551 1551 NUM ct-9360 166 7 . . PUNCT ct-9360 167 1 36 36 NUM ct-9360 167 2 . . PUNCT ct-9360 168 1 ceres ceres PROPN ct-9360 168 2 k k PROPN ct-9360 168 3 , , PUNCT ct-9360 168 4 fitzgerald fitzgerald PROPN ct-9360 168 5 h h PROPN ct-9360 168 6 , , PUNCT ct-9360 168 7 quiznon quiznon PROPN ct-9360 168 8 ks ks PROPN ct-9360 168 9 , , PUNCT ct-9360 168 10 et et PROPN ct-9360 168 11 al al PROPN ct-9360 168 12 : : PUNCT ct-9360 168 13 immunohistochemical immunohistochemical ADJ ct-9360 168 14 labeling labeling NOUN ct-9360 168 15 of of ADP ct-9360 168 16 low low ADJ ct-9360 168 17 - - PUNCT ct-9360 168 18 density density NOUN ct-9360 168 19 lipoprotein lipoprotein ADJ ct-9360 168 20 receptor receptor NOUN ct-9360 168 21 and and CCONJ ct-9360 168 22 scavenger scavenger NOUN ct-9360 168 23 receptor receptor NOUN ct-9360 168 24 class class NOUN ct-9360 168 25 b b PROPN ct-9360 168 26 type type NOUN ct-9360 168 27 1 1 NUM ct-9360 168 28 are be AUX ct-9360 168 29 increased increase VERB ct-9360 168 30 in in ADP ct-9360 168 31 canine canine NOUN ct-9360 168 32 lymphoma lymphoma NOUN ct-9360 168 33 . . PUNCT ct-9360 169 1 front front ADJ ct-9360 169 2 vet vet NOUN ct-9360 169 3 sci sci PROPN ct-9360 169 4 2019;11:340 2019;11:340 NOUN ct-9360 169 5 . . PUNCT ct-9360 170 1 37 37 NUM ct-9360 170 2 . . PUNCT ct-9360 171 1 menon menon PROPN ct-9360 171 2 k k NOUN ct-9360 171 3 : : PUNCT ct-9360 171 4 regulation regulation NOUN ct-9360 171 5 of of ADP ct-9360 171 6 luteinizing luteinize VERB ct-9360 171 7 hormone hormone NOUN ct-9360 171 8 receptor receptor NOUN ct-9360 171 9 expression expression NOUN ct-9360 171 10 by by ADP ct-9360 171 11 an an DET ct-9360 171 12 rna rna NOUN ct-9360 171 13 binding bind VERB ct-9360 171 14 protein protein NOUN ct-9360 171 15 : : PUNCT ct-9360 171 16 role role NOUN ct-9360 171 17 of of ADP ct-9360 171 18 erk erk NOUN ct-9360 171 19 signaling signal VERB ct-9360 171 20 . . PUNCT ct-9360 172 1 indian indian PROPN ct-9360 172 2 j j PROPN ct-9360 172 3 med med PROPN ct-9360 172 4 res re NOUN ct-9360 172 5 2014;140 2014;140 NUM ct-9360 172 6 , , PUNCT ct-9360 172 7 suppl suppl ADJ ct-9360 172 8 s1:112 s1:112 PROPN ct-9360 172 9 - - PUNCT ct-9360 172 10 119 119 NUM ct-9360 172 11 . . PUNCT ct-9360 173 1 38 38 NUM ct-9360 173 2 . . PUNCT ct-9360 174 1 davis davis PROPN ct-9360 174 2 js js PROPN ct-9360 174 3 , , PUNCT ct-9360 174 4 may may AUX ct-9360 174 5 jv jv PROPN ct-9360 174 6 , , PUNCT ct-9360 174 7 keel keel PROPN ct-9360 174 8 ba ba PROPN ct-9360 174 9 : : PUNCT ct-9360 174 10 mechanisms mechanism NOUN ct-9360 174 11 of of ADP ct-9360 174 12 hormone hormone NOUN ct-9360 174 13 and and CCONJ ct-9360 174 14 growth growth NOUN ct-9360 174 15 factor factor NOUN ct-9360 174 16 action action NOUN ct-9360 174 17 in in ADP ct-9360 174 18 the the DET ct-9360 174 19 bovine bovine PROPN ct-9360 174 20 corpus corpus PROPN ct-9360 174 21 luteum luteum PROPN ct-9360 174 22 . . PUNCT ct-9360 175 1 theriogenology theriogenology NOUN ct-9360 175 2 1996;45:1351 1996;45:1351 NUM ct-9360 175 3 - - SYM ct-9360 175 4 1380 1380 NUM ct-9360 175 5 . . PUNCT ct-9360 175 6 39 39 NUM ct-9360 175 7 . . PUNCT ct-9360 176 1 reshef reshef NOUN ct-9360 176 2 e e NOUN ct-9360 176 3 , , PUNCT ct-9360 176 4 lei lei PROPN ct-9360 176 5 zm zm PROPN ct-9360 176 6 , , PUNCT ct-9360 176 7 rao rao PROPN ct-9360 176 8 cv cv PROPN ct-9360 176 9 , , PUNCT ct-9360 176 10 et et PROPN ct-9360 176 11 al al PROPN ct-9360 176 12 : : PUNCT ct-9360 176 13 the the DET ct-9360 176 14 presence presence NOUN ct-9360 176 15 of of ADP ct-9360 176 16 gonadotropin gonadotropin NOUN ct-9360 176 17 receptors receptor NOUN ct-9360 176 18 in in ADP ct-9360 176 19 nonpregnant nonpregnant ADJ ct-9360 176 20 human human ADJ ct-9360 176 21 uterus uterus NOUN ct-9360 176 22 , , PUNCT ct-9360 176 23 human human ADJ ct-9360 176 24 placenta placenta NOUN ct-9360 176 25 , , PUNCT ct-9360 176 26 fetal fetal ADJ ct-9360 176 27 membranes membrane NOUN ct-9360 176 28 , , PUNCT ct-9360 176 29 and and CCONJ ct-9360 176 30 decidua decidua PROPN ct-9360 176 31 . . PUNCT ct-9360 177 1 j j PROPN ct-9360 177 2 clin clin PROPN ct-9360 177 3 endocrinol endocrinol VERB ct-9360 177 4 metab metab PROPN ct-9360 177 5 1990;70:421 1990;70:421 PROPN ct-9360 177 6 - - SYM ct-9360 177 7 430 430 NUM ct-9360 177 8 . . PUNCT ct-9360 177 9 40 40 NUM ct-9360 177 10 . . PUNCT ct-9360 178 1 flint flint PROPN ct-9360 178 2 c c X ct-9360 178 3 , , PUNCT ct-9360 178 4 gust gust PROPN ct-9360 178 5 s s PROPN ct-9360 178 6 , , PUNCT ct-9360 178 7 kutzler kutzler PROPN ct-9360 178 8 ma ma PROPN ct-9360 178 9 : : PUNCT ct-9360 178 10 luteinizing luteinize VERB ct-9360 178 11 hormone hormone NOUN ct-9360 178 12 receptor receptor NOUN ct-9360 178 13 mediated mediate VERB ct-9360 178 14 proliferation proliferation NOUN ct-9360 178 15 of of ADP ct-9360 178 16 isolated isolated ADJ ct-9360 178 17 canine canine PROPN ct-9360 178 18 t t PROPN ct-9360 178 19 lymphoma lymphoma NOUN ct-9360 178 20 cells cell NOUN ct-9360 178 21 . . PUNCT ct-9360 179 1 clinical clinical ADJ ct-9360 179 2 theriogenology theriogenology NOUN ct-9360 179 3 2019;11:477 2019;11:477 NOUN ct-9360 179 4 . . PUNCT ct-9360 180 1 41 41 NUM ct-9360 180 2 . . PUNCT ct-9360 181 1 beijerink beijerink VERB ct-9360 181 2 nj nj PROPN ct-9360 181 3 , , PUNCT ct-9360 181 4 buijtels buijtel VERB ct-9360 181 5 jj jj PROPN ct-9360 181 6 , , PUNCT ct-9360 181 7 okkens okkens PROPN ct-9360 181 8 ac ac PROPN ct-9360 181 9 , , PUNCT ct-9360 181 10 et et PROPN ct-9360 181 11 al al PROPN ct-9360 181 12 : : PUNCT ct-9360 181 13 basal basal PROPN ct-9360 181 14 and and CCONJ ct-9360 181 15 gnrh gnrh NOUN ct-9360 181 16 - - PUNCT ct-9360 181 17 induced induce VERB ct-9360 181 18 secretion secretion NOUN ct-9360 181 19 of of ADP ct-9360 181 20 fsh fsh NOUN ct-9360 181 21 and and CCONJ ct-9360 181 22 lh lh PROPN ct-9360 181 23 in in ADP ct-9360 181 24 anestrous anestrous ADJ ct-9360 181 25 versus versus ADP ct-9360 181 26 ovariectomized ovariectomize VERB ct-9360 181 27 bitches bitch NOUN ct-9360 181 28 . . PUNCT ct-9360 182 1 theriogenology theriogenology NOUN ct-9360 182 2 2007;67:1039 2007;67:1039 PROPN ct-9360 182 3 - - SYM ct-9360 182 4 1045 1045 NUM ct-9360 182 5 . . PUNCT ct-9360 183 1 clinical clinical ADJ ct-9360 183 2 theriogenology theriogenology NOUN ct-9360 183 3 • • NOUN ct-9360 183 4 volume volume NOUN ct-9360 183 5 13 13 NUM ct-9360 183 6 number number NOUN ct-9360 183 7 1 1 NUM ct-9360 183 8 • • NUM ct-9360 183 9 march march NOUN ct-9360 183 10 2021 2021 NUM ct-9360 183 11 44 44 NUM